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ABSTRACT 
 Cerebral aneurysms are unstable localized dilations of an artery wall located in the 
vasculature of the brain that are susceptible to rupture. Current treatments of aneurysms, 
both surgical and endovascular, involve isolation of the weakened area of artery from the 
rest of the vasculature. However, current filling methods do not result in optimal healing. 
Therefore, we are developing an alternative filling method using shape memory polymer 
(SMP) foams. This dissertation addresses multiple post processing methods and 
characterization of these SMP foams. The goals for characterizations addressed include 
1) microstructure, 2) radio-opacity, 3) biocompatibility, 4) mechanical reticulation, 5) 
flow visualization via magnetic resonance imaging and 6) permeability measurements.  
 The microstructure of the SMP foams was imaged via micro-computed tomography 
imaging methods at high resolution, 4 µm/voxel. At this resolution we were able to 
resolve membranes, struts and obtain 3D models of the foam for computational fluid 
dynamic simulations. Histogram data of average pore cells sizes in multiple axes were 
also measured. It was shown that these materials are anisotropic and heterogeneous.  
 Increased radio-opacity via loading methods resulted in x-ray based visualization of 
devices made of these materials during endovascular implantation. The addition of high-z 
element particulates for radio-opacity resulted in a stronger or composite version of the 
material.  
 It was shown that these shape memory polymer foams were biocompatible when 
implanted in a porcine aneurysm model. The implants elicited healing, were completely 
isolated from the parent vessel and covered with a complete endothelial cell layer at 
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ninety days. 
 A non-destructive mechanical reticulation device was made to puncture the 
membranes of the foams and thereby increase flow permeation. The permeability, or 
pressure drop induced by the samples was measured. Permeability results showed that 
with the increased amount of mechanical reticulation resulted in increased permeability 
of these materials. Flow visualization within the samples was achieved via MRI at sub 
pore cell resolution. 
 All of this research aids in not only the understanding but also the development of 
these materials as a viable medical device for the treatment of intracranial aneurysms and 
other vascular applications.  
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1. INTRODUCTION 
A cerebrovascular accident (CVAs) is a sudden lack of oxygen to a portion of the 
brain, resulting in death of the adjacent brain cells, due to a blockage in the vasculature 
or hemorrhage, commonly known as ischemic or hemorrhagic stroke respectively.12 
CVAs occur in more than 700,000 Americans per year,12, 93, 13 and approximately 
100,000 of the 700,000 occur after an aneurysm rupture.12, 5, 6 Cerebral aneurysms are 
localized dilations of the artery wall located in the vasculature of the brain, and are 
unstable in structure due to a lack of an intimal elastic lamina and a thickened hyalinized 
intima and thus, have the tendency to rupture.55 Upon aneurysm rupture, a subarachnoid 
hemorrhage, occurring in approximately 10 per 100,000 people,23, 56 results in a 
cerebrovascular accident, a potentially fatal or a severely debilitating event.23  
These cerebral arterial malformations are often spherical in shape and are 
commonly referred to as berry aneurysms, which affect approximately 3-5% of the 
general population.92, 23 Berry aneurysms are congenital, or linked to genetic inheritance, 
with an increased susceptibility to develop lesions at different sites within the cerebral 
vasculature, especially within the circle of Willis.90, 23 Due to the high impact on patient 
mortality and morbidity, early and effective treatment of a berry aneurysm prior to 
rupture is imperative for increasing the patient’s survival rate and quality of life.23  
The current FDA approved treatments for such aneurysms involve isolation of 
the weakened vessel via surgical clipping,62 endovascular embolization through the use 
of flexible platinum coils, called Guglielmi Detachable Coils (GDC), inserted into the 
dome of the aneurysm, or filling with an in-situ polymerizing radiopaque material, such 
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as Onyx Liquid Embolic Eystem (Onyx HD-500) (Onyx; MicroTherapeutics, Irvine, 
CA, USA).  Both the GDC coils and the polymerizing material are introduced to the 
aneurysm dome via a micro catheter. These filling treatments involve isolation of the 
weakened area of artery from the rest of the vasculature, resulting in the remodeling of 
the endothelium, the innermost layer of the artery. Further, these treatments are not 
perfect in avoiding aneurysm rupture and subsequent hemorrhage, but they have greatly 
improved the outcome compared to untreated aneurysms.12 
The current treatments for intracranial aneurysms give options for 
interventionists; however there are limitations and risks associated with each of the 
designs. Surgical clipping involves a craniotomy, an invasive surgery of the brain, which 
can have serious inherent risks to the patient. Furthermore, surgical clipping is not 
always possible due to an inaccessible location of the aneurysm within the brain or the 
patient being a nonviable candidate for surgery due to age or weakness. As a result of 
these limitations on surgical clipping, endovascular treatment by filling devices has 
become the preferred treatment among physicians.23  
Of the two available filling treatments, GDC platinum coils are the favored 
treatment for cerebral aneurysms.62 The mechanism of aneurysm treatment by GDC is to 
fill the sac with multiple clot-promoting platinum coils one-at-a-time until the volume 
appears to be filled, as observed via fluoroscope imaging.37 Specifically, the coils are 
navigated through the arterial system from the femoral artery to the site of the aneurysm, 
guided by contrast enhanced fluoroscope images of the patient, utilizing the Seldinger 
method, which involves placement of the micro catheter over a micro guidewire to 
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navigate the tortuous vasculature of the brain.83, 23 Filling of the aneurysm is then 
achieved when there is a lack of contrast medium injected into the dome; at that point no 
more coils would be inserted. Although inherently extremely flexible, the platinum coils 
are available in engineered variations that tailor the flexibility, thickness and length. In 
addition, GDCs have the ability to wind themselves into a circular shape until they create 
a scaffold for which blood can coagulate and form a stable clot. Each platinum coil is 
detached at a solder point via electrical current, causing the coil to become positively 
charged.23 This positive charge makes the coil attractive to the negatively charged blood 
components23, 37 and thus initiates a clot via electrothrombosis.37 
While being the favored treatment for intracranial aneurysms, GDCs do possess 
drawbacks, such as coil compaction and subsequent formation of new side aneurysms 
adjacent to the original aneurysm,40 low packing volume (less than 50% of the volume68, 
44, 49) leading to recanalization or refilling,38 migration of loose coils into the parent 
artery 96, and although rare, potential puncture of the aneurysm dome.26 Additionally, 
GDCs are not very successful at treating aneurysms with neck diameters greater than 4 
mm.68 In these large neck aneurysms, approximately one-third of GDC treated 
aneurysms either rebleed or recanalize.30, 63, 75, 89  Therefore, although GDC treatment is 
the preferred filling method by interventionlists, there is room for improvements in the 
safety and efficacy of these devices.  
A more recent method of filling and isolation of the aneurysm involve a soft 
spongy material. Onyx is a material that is mechanically more compliant with the arterial 
wall than the GDC metal coils, potentially having a better in-vivo healing response and 
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overall stability in comparison to the GDC filling method. Because Onyx is a spongy 
polymer only after in-situ polymerization, it has the potential to migrate,94 or leak out, of 
the dome of the aneurysm while still in its liquid state. The consequences associated with 
the migration are substantial due to the potential to block one of the parent or 
downstream arteries and thereby causing infarction. In addition, Onyx has been proven 
to be a viable treatment for small-necked aneurysms over time,18 but is not as stable for 
permanent treatment of giant aneurysms.18  
The drawbacks of the commonly accepted treatments have spurred developments 
of alternative aneurysm filling methods. Some of these technologies include treatment 
with multiple commercial devices42, hydrogel polymer38, hybrid metal and hydrogel 
coils1, and polymer foams for filling of the dome.98, 99, 68, 86  
This dissertation focuses on technology which involves shape memory polymer 
(SMP) foams that have been developed as an aneurysm filling method87, 25, 68 and 
vascular occlusion device. SMP foams are materials that have the ability to be fabricated 
into an initial shape, such as a sphere. This initial geometry can then be deformed 
subsequent to raising the material’s temperature above its transition temperature, for 
these materials its glass transition temperature, through application of a force. A 
continued application of the force while cooling the material below its glass transition 
temperature, programs the material into a secondary shape. An example of a secondary 
shape is a crimped, small diameter cylinder. When the polymer is in a cylinder of small 
diameter it is in a secondary, or temporary shape. The aneurysm or artery filling device 
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would remain in its temporary shape until it is delivered to the dome of the aneurysm, or 
patent artery respectively. 
These SMP foams are based off of polyurethane chemistry97 and have potentially 
superior biocompatibility in-vivo.15 Although superior healing may result from the use of 
SMP polymer foams as a filling material, these polymer foams are not visible under 
conventional patient imaging modalities, which hinders their use by clinicians. Part of 
this research sought to resolve the lack of radio-opacity of low-density SMP foams and 
thus advance this technology toward a marketable medical device. Another aspect to this 
research involved characterization of the materials via imaging and mechanical methods, 
such as mechanical testing and characterization of foams while under the influence of 
flow. Another aspect of characterization includes the in vivo tissue response of these 
foams to implants within porcine aneurysm and vascular occlusion models. Radio-
opacity, tissue interaction and hemodynamic interactions were determined in this 
research.  
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2. IN VIVO RESPONSE TO AN IMPLANTED SHAPE MEMORY 
POLYURETHANE FOAM IN A PORCINE ANEURYSM MODEL*1 
 
 
 
2.1 Overview 
Cerebral aneurysms treated by traditional endovascular methods using platinum 
coils have a tendency to be unstable, either due to chronic inflammation, compaction of 
coils, or growth of the aneurysm. We propose to use alternate filling methods for the 
treatment of intracranial aneurysms using polyurethane based shape memory polymer 
(SMP) foams. SMP polyurethane foams were surgically implanted in a porcine 
aneurysm model to determine biocompatibility, localized thrombogenicity, and their 
ability to serve as a stable filler material within an aneurysm. The degree of healing was 
evaluated via gross observation, histopathology and low vacuum scanning electron 
microscopy (LV-SEM) imaging after zero, thirty and ninety days. Clotting was initiated 
within the SMP foam at time zero (less than one hour exposure to blood prior to 
euthanization), partial healing was observed at thirty days, and almost complete healing 
had occurred at ninety days in vivo, with minimal inflammatory response. 
  
                                                
* Reprinted with permission from “In vivo response to an implanted shape memory 
polyurethane foam in a porcine aneurysm model” by Jennifer N. Rodriguez, Fred J. 
Clubb, Thomas S. Wilson, Matthew W. Miller, Theresa W. Fossum, Jonathan Hartman, 
Egemen Tuzun, Pooja Singhal and Duncan J. Maitland, 2014. Journal of Biomedical 
Materials Research Part A, Volume 102, pages 1231-1242, Copyright 2014 Wiley 
Periodicals, Inc., License Number: 3345431422339. 
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2.2 Introduction 
2.2.1 Cerebral aneurysms and subarachnoid hemorrhage 
Aneurysms are geometric structural abnormalities of the vasculature manifested 
as a bulging or out pouching of the vessel wall. These can occur almost anywhere in the 
body but are particularly worrisome when they are present in the intracranial circulation. 
Due to the thinned, weakened wall, aneurysms are at risk of rupture, and in the United 
States, approximately one in 50 adults has an unruptured aneurysm.62 Upon rupture, a 
subarachnoid hemorrhage (SAH) is said to have occurred, and this can be a severely 
debilitating or fatal event.7 Approximately 30,000 people per year in the United States 
suffer SAH from a ruptured cerebral aneurysm.62 
2.2.2 Current treatments and limitations 
Current treatment of these arterial abnormalities involves isolation from the 
normal vasculature, and subsequent stabilization of the vulnerable portion of the artery. 
Isolation methods involve either surgical clipping or filling of the aneurysm with 
platinum coils, thereby preventing subsequent rupture. Surgical clipping, although 
highly effective for treating aneurysms,44 involves invasive surgery in the form of a 
craniotomy. Additionally, for patients who are not viable candidates for surgery or 
whose aneurysm is in an area of the brain in which surgical access involves increased 
risk, surgery is either not an option or not the preferred option.20,62,47 For these patients 
and many treatment centers, filling methods are the preferred treatment of aneurysms.10, 
11  
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Filling methods involve endovascular navigation to the site of the aneurysm with 
the aid of fluoroscopy and intra arterial injection of iodinated contrast for vessel and 
aneurysm opacification. The aneurysm is then entered with a microcatheter and filled, 
reducing the pressure on the aneurysm wall and promoting clotting and healing within 
the aneurysm. For optimal treatment, the filling material would become incorporated 
into the aneurysm sac and isolated from the parent vessel by the formation of an 
endothelial cell layer and neointima proliferation across the neck of the aneurysm. This 
encasing of the filler and restoration of the parent vessel essentially isolates the 
aneurysm sac from blood flow, permanently stabilizing the weakened portion of the 
artery and preventing subsequent rupture.   
Various materials are currently used for endovascular treatment of aneurysms. 
The most common is a soft, wound platinum coil. There are variations of this, including 
hydrogel- coated coils and polyglycolic polylactic acid coated or impregnated coils. 
These devices have proven to be clinically successful at filling small aneurysms (<4 mm 
in diameter).68 However, these devices could be improved with respect to their 
biological activity 50 and safety of delivery.26 Previously it has been demonstrated by 
Murayama et al.63 and Szikora et al.88, despite the relatively inert nature of platinum, 
these coils can be an ongoing source of inflammation within the aneurysm after 
implantation. The latter group reported that after multiple years, bare platinum coils are 
still not completely endothelialized at the aneurysm and parent artery interface; and 
therefore, the aneurysm is not optimally stabilized.88 Coils have a tendency to have low 
filling volume as compared to total aneurysm volume68,43,50 and may compact over time 
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40, allowing aneurysm recanalization.38,30,64,75, 89 This results in re-exposure of the 
aneurysm wall and subsequent rupture or re-rupture or can potentially result in formation 
of aneurysms adjacent to the original aneurysm.40 Recanalization may require additional 
treatment, thus adding to the overall cost of treatment and increasing risk to the patient. 
Other efficacy issues surrounding these coils involve migration of coils into the parent 
vessel57,91, difficulty in treating wide necked aneurysms20, and potential rupture of the 
aneurysm during coil delivery26, often with devastating results.    
Another material used for endovascular treatment of aneurysms is a liquid 
ethylene-vinyl copolymer (Onyx HD- 500, ev3, Irvine, CA). This entails placing a 
balloon catheter in the parent artery over the neck of the aneurysm, temporarily halting 
blood flow, while the polymer is injected into the aneurysm via a second microcatheter. 
The material polymerizes in situ. This technique does not guarantee a seal at the 
balloon–artery interface and can potentially lead to the occlusion of the parent artery or 
of distal arteries. Also, complications can arise if the material migrates into the parent 
artery.24, 61 
2.2.3 Proposed treatment of intracranial aneurysms by shape memory polymer foams 
Previously, polymer coils and foams have been proposed as an alternative filling 
material for treatment of cerebral aneurysms.60, 64, 68, 39, 77 Polymer coated platinum coils 
have also been used for aneurysm treatment and have been shown to have favorable 
results in vivo. However, despite encouraging animal studies50, 88, the benefits have not 
been borne out clinically, likely due to the relatively rapid biodegradability.73, 21 It has 
also been shown that polyurethane foams have favorable biocompatibility in vivo for 
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larger aortic aneurysm animal models.76 In this research, we focus on the 
biocompatibility of polyurethane-based shape memory polymer (SMP) foams as an 
aneurysm filling material. We sought to observe the tissue response after implantation of 
a SMP foam device in a swine aneurysm model. The swine vein pouch aneurysm model, 
reported by Guglielmi et al.36, 71 in 1994, was chosen due to its relatively low cost, large 
arteries, and veins within the neck and similar fibrinolytic and coagulation system to 
humans. This model is also significant due to the similarity in the achievable dimensions 
of aneurysm sacs that can be made during the process of attaching the vein pouch to the 
artery. Similarities in dimension and blood interactions between the device and the in 
vivo environment within the swine model, facilitate extrapolation of the pathological 
data acquired from this study to the potential reaction to the implant within humans.36 
SMPs are materials that have the ability to be made into a primary shape, and 
upon an increase in the bulk temperature of the material above its transition temperature, 
can be deformed and programmed into a temporary shape. Programming of these 
materials occurs when the temperature of the material is brought below its transition 
temperature while maintaining the deformation, for our device a crimped temporary 
shape would be desirable [Fig. 1(A)]. A device made from these materials would remain 
in this programmed shape until it encounters an additional stimulus that raises the 
material’s temperature above its transition temperature, at which point it would recover 
to its primary shape, for our device an expanded shape to fill the aneurysm sac would be 
desirable [Fig. 1(B, C)]. This ability to change from one shape to another via the 
application of a stimulus has made these materials attractive for medical device  
11 
 
 
 
Figure 1: Proposed SMP foam devices for aneurysm filling. (a) crimped (temporary 
shape) SMP foam device delivered to the aneurysm via catheter, (b) intermediate image 
of the foam expanding within the aneurysm, as it recovers to its permanent shape via 
stimuli, (c) treated aneurysm with fully expanded foam, (d) a detail of the foam, scale 
bar is 500 mm, and (e) foam devices (scale bar is 5 mm). 
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development.39 These polymers possess characteristics similar to other polymeric 
materials, including the ability to be molded or foamed into an open celled architecture.  
Due to these favorable characteristics, we have developed polyurethane-based 
SMP foam for the treatment of intracranial aneurysms.84 These low-density foams have 
an expansion force less than that which would pose risk of aneurysm rupture.46 Both the 
foams and neat materials have demonstrated biocompatibility in vitro.36, 84 
Biocompatibility of the foams also has been demonstrated in vivo.77 To further verify 
biocompatibility in vivo, we have implanted these foams in a porcine vein pouch 
aneurysm model36 for 0 (<1 h contact with the circulation before sacrifice), 30, and 90 
days. Gross evaluation, low-vacuum scanning electron microscopy (LV-SEM), and 
histology were performed to assess the tissue response induced by the implanted foams. 
Inflammation induced by the U.S. Food and Drug Administration approved silk and 
polypropylene sutures (7-0 ProleneTM; Ethicon, San Angelo, TX) used to create the 
experimental aneurysms was also quantified for comparison. 
2.3 Materials and methods 
2.3.1 SMP fabrication  
Filling devices were fabricated out of polyurethane SMP foams based on the H60 
chemistry reported by Singhal et al.84 An isocyanate prepolymer was prepared by mixing 
38% of the total equivalents of hexamethylene diisocyanate (TCI America, Portland, 
OR) with the hydroxyl monomers N,N,N’,N’-tetrakis(hydroxypropyl)ethylenediamine 
(HPED; Sigma-Aldrich, St. Louis, MO) and triethanolamine (Sigma- Aldrich) at which a 
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single phase was formed. This prepolymer was allowed to cure at room temperature for 
2 days before foaming. At the point of foam fabrication, the balance of hydroxyl 
monomers to isocyanate monomers, had a net isocyanate index of 105. These monomers 
were then added to the prepolymer. Subsequent addition of catalysts, surfactants, water 
(chemical blowing agent), and Enovate (Honeywell, Morristown, NJ; Physical blowing 
agent), were added and mixed to achieve a homogeneous solution.32 This solution was 
then put in the oven at 90 º C where it rose. The foam was then heat cured for 20 min in 
the oven, followed by a room temperature cure for at least 2 days.   
2.3.2 Device fabrication  
Spherical SMP foam devices were fabricated using a scalpel into dimensions 
ranging from 8 to 12 mm in diameter [Fig. 1(E)]. Varying sizes of SMP foam devices 
were fabricated to allow the vascular surgeon to select the appropriate size to fill the 
aneurysm. 
2.3.3 Cleaning  
Removal of surfactants and catalysts from the devices were achieved by cleaning 
via 0.1 M hydrochloric acid (BDH Chemicals, West Chester, PA) and detergent, Contrad 
VR 70 solution (Decon Laboratories, King of Prussia, PA). The devices were initially 
submerged in 0.1 N hydrochloric acid in glass vials, and placed in a sonication bath for 2 
h. This step was followed by rinsing the samples in deionized water, and changing the 
acidic solution in the vial to an 80:20 vol percent, deionized water-ContradVR 70 
solution. They were then placed into the sonication bath for 15 min. The samples were 
washed multiple times in deionized water to remove residual detergent (removal of 
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detergent was determined by an absence of bubble generation upon shaking). After the 
samples were free of detergent, they submerged in a vial containing deionized water and 
placed back into the sonication bath for another 15 min. These steps were repeated once 
more to ensure thorough cleaning and complete removal of residual mobile species. The 
cleaned samples were then dried in an oven over night, approximately 12 hours, at 50 C 
under vacuum. The dried samples were visually examined under magnification for any 
deformation or presence of loose struts on the surface, and a scalpel was used to 
manually trim loose struts and to restore dimensions and spherical shape. 
2.3.4 Sterilization  
Each device was individually sealed in a sterilization pouch and sterilized by 
ethylene oxide (EtO), and allowed to de-gas for 48 h before implantation. 
2.3.5 Porcine animal model  
  All animal experiments were conducted in accordance with policies set by the 
Texas A&M University Institutional Animal Care and Use Committee, and met all 
federal requirements, as defined in the Animal Welfare Act, the Public Health Service 
Policy, and the Humane Care and Use of Laboratory Animals. Additionally, NIH 
guidelines (or for non- U.S. residents similar national regulations) for the care and use of 
laboratory animals (NIH Publication #85-23 Rev. 1985) were observed. A porcine vein 
pouch saccular sidewall aneurysm model was utilized in this study.36 
Saccular sidewall aneurysms were created in 3 to 4 month old swine weighing 
approximately 30 to 40 kg. Anesthesia was induced via intramuscular injection of 
ketamine, xylazine, and acepromazine (20, 2, and 0.2 mg/kg, respectively) with 
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intubation and use of isoflurane for maintenance of anesthesia. Using sterile technique a 
10 cm incision was made in the midline of neck. After reflecting the sternocleidomastoid 
muscle medially, a 4-cm long segment of the external jugular vein was isolated and 
excised after a ligature is placed at each end of the segment. This segment of the vein 
was then divided transversely, yielding two 2 cm open-ended pouches. The carotid 
arteries were then subsequently exposed and cleaned of adventitia. Vascular clamps 
were placed at each end of the area of interest on the artery to provide temporary vessel 
occlusion. A 7 mm arteriotomy was then made, and end-to-side anastomosis of the 
venous pouch to the carotid artery will be performed using 7-0 ProleneTM (Ethicon) 
sutures. An aneurysm between 8 and 10 mm in diameter was then created on each 
carotid artery, which resulted in two aneurysms per animal. After confirmation of 
hemostasis, the subcutaneous tissues were closed.   
Angiography was performed to visualize the integrity of the aneurysm and to 
assess for any premature thrombosis. An SMP device was soaked in 37 C saline and then 
placed in each aneurysm by opening the top suture and reclosing after proper placement 
had been achieved. Aneurysm filling and integrity were assessed via angiography after 
implantation of the SMP devices. The implanted devices remained in place for 0 (<1 h 
exposure to blood before euthanization), 30, or 90 days. At the end of each implantation 
time point the animals were sacrificed. Each of the aneurysms and their parent vessels 
were isolated, harvested, and preserved with formalin for gross and histological 
evaluation. 
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2.3.6 Gross evaluation of healing 
The parent vessels were bisected parallel to the direction of blood flow to allow 
visualization of the aneurysm neck. Each aneurysm was observed at the main artery and 
graft interface for endothelialization of the lesion en face. 
2.3.7 Microscopic evaluation of healing  
LV-SEM imaging was used to determine the degree of endothelialization at the 
parent vessel and device interface (i.e., across the neck of the aneurysm). Histology was 
used to determine the amount of healing and inflammation at the dome of the aneurysm. 
Multiple stains including hematoxylin and eosin (H&E), Masson’s trichrome, and 
Mallory’s phosphotunsic acid hematoxylin (PTAH) were used.  
2.3.8 LV-SEM: endothelialization 
A major component of aneurysm stabilization and healing is endothelialization at 
the device and parent vessel interface and restoration of the intima of the parent artery 
across the aneurysm neck. Presence of neointima and progression of the covering were 
assessed via LV-SEM at each time point. 
2.3.9 Histopathology 
Multiple stains were used to characterize the healing in and around the 
aneurysms and to evaluate the degree of inflammation present. The pathology slides 
were scanned by an AperioVR ScanScopeVR slide scanner, and the resulting images 
were evaluated by ImageScopeVR (Aperio Technologies, Vista, CA), a pathology slide 
viewing software. Magnifications reported in histology figures are based on these 
scanned images.   
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H&E is a microatomic stain that provides information about the general 
pathology of a tissue and was used as a general stain to evaluate inflammation and 
neovascularization. The nuclei of cells are stained blue/black by hematoxylin.14 Eosin is 
an acid dye that stains cytoplasm various shades of red, pink, and orange.14   
Masson’s trichrome is one of two connective tissue stains that were used to 
evaluate elastin and fibrin. With this stain, collagen and reticular fibers appear 
blue/green, cytoplasm and red blood cells red, and the nuclei black/gray.14, 74 Mallory’s 
PTAH is the second connective tissue stain used. This stain was used to determine the 
amount of residual fibrin at the aneurysm dome. PTAH is also used to determine the 
amount of collagen and elastin that has been deposited. This stain colors nuclei of cells a 
deep blue, fibrin fibers a lighter blue, collagen reddish, and coarse elastin fibers bluish.14 
2.4 Results  
2.4.1 Aneurysm embolization  
Based on fluoroscopic imaging performed during implantation and LV-SEM and 
histological evaluation at 0, 30, and 90 days after implantation, all aneurysms showed 
complete filling with SMP foam at all time points.   
2.4.2 Gross evaluation of healing 
Gross evaluation of aneurysm healing is summarized in column A and B of 
Figure 2. For 0 day, the surgical site was clean as expected, and the polymer had visible 
thrombus throughout the matrix where it had been in contact with blood flow. For the 
30-day implants, the outer surface was composed of a white to slightly opaque dense 
connective tissue, with tan to golden brown patches. In Figure 2(B.30), the carotid artery 
  18 
was bisected to expose the en face view of the ostium (neck) of the aneurysm sac. The 
surface of the ostium was white, glistening and appeared to cover the aneurysm neck. 
However, there appeared to be focal areas where polymer was exposed. For implants 
that had remained in vivo for 90 days, the external surface of the aneurysms showed 
multifocal adhesions of dense white connective tissue with tan to golden brown 
coloration. The carotid artery was bisected to visualize the ostium and it appeared to be 
white, glistening, intact and with no evidence of exposed polymer Figure 2(B.90). 
2.4.3 Microscopic evaluation of healing 
2.4.3.1 LV-SEM: endothelialization 
  Figure 2, columns C and D correspond to the middle lower edge of and middle 
of the en face regions respectively, and summarize the endothelialization and topography 
at the foam/parent artery interface with subsequent rows indicating the results of the 
three time points: 0, 30, and 90 days. At 0 days the LV-SEM micrographs indicate 
patchy aggregates of fibrin-enmeshed red blood cells on the surface of the polymer 
implant. After 30 days there was presence of a discontinuous endothelial layer over the 
polymer struts. En face images of the ostium at 90 days show an endothelial cell layer 
comprised of cobblestone patterned and spindle-shaped endothelial cells. These 
endothelial cells aligned parallel with the direction of blood flow in the parent vessel. 
The first row in Table 1 summarizes the topographical LV-SEM evaluation of all 
aneurysms. After 90 days, all of the aneurysms were completely covered by endothelial 
cells.  
 
 
 
Figure 2: Gross and microscopic figure. Gross and microscopic evaluation of the healing response of the implanted SMP 
foams: (A.0) 30-min implant of SMP foam in vein pouch model. (B.0) en face view of the aneurysm artery interface after 30 
min in vivo. (C.0) LV-SEM shows partial protrusion of foam material into the lumen. (D.0) the porous surface in contact with 
the vessel lumen has patchy aggregates of fibrin enmeshed erythrocytes attached to the struts of the foam. (A.30) dissected 
aneurysm in situ after 30 days of implantation. The outer surface of the aneurysm was composed of dense white to slightly 
opaque connective tissue with patchy tan to golden brown discoloration. (B.30) excised aneurysm with two clips that mark the 
cranial end. In patchy areas this outer capsule was adherent to adjacent skeletal muscle. The left carotid artery was bisected 
parallel with the long axis to visualize the ostium of the left aneurysm sac. The cranial end was labeled with two clips. (C.30) 
most of the ostium shows an imprint of polymer foam beneath the endothelial covering. (D.30) after 30 days of implantation, 
there is a focal area of disruption and polymer exposed to the lumen. (A.90) the right carotid in situ showed an outer surface of 
artery and aneurysm with multifocal adhesions of dense white connective tissue. (B.90) the right carotid artery was bisected 
parallel with the long-axis to visualize the ostium of the left aneurysm sac. The surface covering the ostium was white, 
glistening and appeared intact. (C.90) the bisected section of artery and en face ostium of aneurysm sac shows an endothelial 
cell covered surface. (D.90) evidence of proliferating mural thrombosis is not present. The endothelial cell morphology across 
the ostium is mostly spindle-shaped and parallel with the long axis. 
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Row 2 of Table 1 summarizes the data regarding mural thrombus at the base of the 
aneurysms evaluated by LVSEM imaging. There was less than 1% of the surface area of 
the base of the aneurysm covered with thrombus after 30 days, and no thrombus 
remaining after 90 days.   
2.4.3.2 Histopathology. Connective tissue: Aneurysm composition 
Row 3 of Table 1 summarizes the composition of the connective tissue of each 
aneurysm at the three time points, which includes multinucleated giant cells, 
macrophages, lymphocytes, and focal aggregates of neutrophils. The amount of 
connective tissues was determined by pathology, in which a cross-section of the dome 
was evaluated. It was shown that at 0 days there were no connective tissue present [Fig. 
3(A.0,B.0)]. At 30 days there were connective tissues present within the aneurysm dome 
between 25 and 75% observed throughout all aneurysms [Fig. 3(A.30,B.30,C.30)]. At 90 
days there was 75% connective tissue present throughout the aneurysms [Fig. 
3(A.90,B.90,C.90)]. 
2.4.3.3 Remnant fibrin present in aneurysm 
  Supporting Information Table S1 summarizes the amount of remnant fibrin, or 
the amount of fibrin that had not been resorbed or fully degraded, throughout the 
aneurysm domes at each time point observed via pathology. At the 0 day time point (less 
than 1 h exposure to blood before euthanization), there was between 6 and 10 % fibrin 
present. After 30 days of implantation, one of seven aneurysms evaluated was composed 
of more than 50 % fibrin, three of seven between 11 and 25 % fibrin, and the remaining 
three had 6–10 % residual fibrin [Fig. 4(A.30,B.30,C.30)]. After 90 days, there was one  
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Figure 3: H&E figure. H&E staining (1x and 4x magnification): (A.0) 1x H&E staining 
of a bisected aneurysm after 30 min of implantation, (B.0) 4x H&E staining of the 
central core of the bisected aneurysm after 30 min of implantation, (C.0) orientation of 
SMP foam implant within the aneurysm dome and parent artery, (A.30) 1x H&E staining 
of a bisected aneurysm after 30 days of implantation, (B.30) 4x H&E staining of the 
central core of the bisected aneurysm after 30 days of implantation, (C.30) 4x H&E 
staining of foam and parent artery interface after 30 days of implantation, (A.90) 1x 
H&E staining of a bisected aneurysm after 30 days of implantation, (B.90) 4x H&E 
staining of the central core of the bisected aneurysm after 90 days of implantation, and 
(C.90) 4x H&E staining of foam and parent artery interface after 90 days of 
implantation. 
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aneurysm composed of between 11 and 25% fibrin, with the remaining five being 
composed of less than 5% fibrin [Fig. 4(A.90,B.90,C.90)].   
2.4.3.4 Connective tissue within the aneurysm 
The first three rows of Table 2 are a summary of the infiltration of dense cellular 
connective tissue within the aneurysms; it is expressed in the form of a percentage of 
infiltration of the aneurysms at each time point throughout the volume of the dome. 
There was no cellular infiltration at 0 days. At 30 days, there was greater than 75% 
cellular infiltration throughout the aneurysm volume [Fig. 5(A.30,B.30,C.30)]. At 90 
days, there was greater than 85% cellular infiltration in all aneurysms [Fig. 
5(A.90,B.90,C.90)].   
2.4.3.5 Inflammation within and around the aneurysm 
The second three rows of Table 2 are a summary of the inflammatory response 
elicited by the foam within the dome of the aneurysms as measured by the average 
number of inflammatory cells present per area evaluated at 250x or 0.025 mm2. 
Inflammation induced by the presence of foam was evaluated at three locations 
throughout the volume which included the anastomosis, central core and the apex of the 
aneurysm. For all areas evaluated at 0 days, there was no significant inflammation due to 
the short in vivo exposure time. At 30 days, most aneurysms exhibited a mild 
inflammation score for all three areas, which consisted of between 5 and 10% 
inflammatory cell infiltrates, which included approximately two to three macrophages or 
lymphocytes or one neutrophil per area evaluated. At 90 days, most aneurysms exhibited 
a minimal inflammation score for all three areas, which consisted of between less than 
 
 
 
Figure 4: PTAH figure. PTAH staining (1x and 4x magnification): (A.30) 1x PTAH staining of a bisected aneurysm after 30 
days of implantation, (B.30) 4x PTAH staining of the central core of the bisected aneurysm after 30 days of implantation, 
(C.30) 4x PTAH staining of foam and parent artery interface after 30 days of implantation, (A.90) 1x PTAH staining of a 
bisected aneurysm after 90 days of implantation, (B.90) 4x PTAH staining of the central core of the bisected aneurysm after 90 
min of implantation, and (C.90) 4x PTAH staining of foam and parent artery interface after 90 days of implantation.  
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Figure 5: Trichrome figure. Trichrome staining (1x and 4x magnification): (A.30) 1x trichrome staining of a bisected aneurysm 
after 30 days of implantation, (B.30) 4x trichrome staining of the central core of the bisected aneurysm after 30 days of 
implantation, (C.30) 4x trichrome staining of foam and parent artery interface after 30 days of implantation, (A.90) 1x 
trichrome staining of a bisected aneurysm after 30 days of implantation, (B.90) 4x trichrome staining of the central core of the 
bisected aneurysm after 90 days of implantation, and (C.90) 4x trichrome staining of foam and parent artery interface after 90 
days of implantation. 
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5% inflammatory cell infiltrates, which included approximately one or less macrophage 
or lymphocytes or one neutrophil per area evaluated.  
Figure 6 is a summary of not only the inflammatory response elicited by the 
foam, but also the inflammation at the suture sites at the periphery of the aneurysms. For 
the foam, at 0 days the average score for all areas evaluated was approximately 0.5, 
which corresponded to zero to two leukocytes per area evaluated. At 30 days the foam 
had an average score of 2.5, which corresponded to three to eight leukocytes per area 
evaluated. At 90 days the foam had an average score of 3, which corresponded to five to 
eight leukocytes per area evaluated. For all time points, and all areas observed, the foam 
elicited an inflammation response, which was slightly higher on the perimeter than 
within the core.  
Suture materials were also evaluated for their inflammation response. At 0 day, 
polypropylene suture material was the only suture material evaluated do to a lack of silk 
incorporated into the tissue during histology, and there were three to eight leukocytes per 
area evaluated. At 30 days, polypropylene suture material induced inflammation 
reflected by presence of four to eight leukocytes per area evaluated. Silk suture at 30 
days elicited eight to 11 leukocytes per area evaluated.  At 90 days, there were five to 11 
leukocytes per area evaluated for polypropylene sutures and eight to 11 leukocytes per 
area evaluated for silk. Additionally, focal mineralization was observed in relation to the 
polypropylene sutures after 30 days and around the silk sutures after 90 days.  
Visual comparison of polymer and suture material inflammatory response can be 
seen in Figure 7(A.30,B.30,C.30,D.30, A.90,B.90,C.90,D.90) for 30- and 90-day time  
 
 
 
Figure 6: Inflammation figure. Average pathology scoring of inflammation (250x magnification, or 0.025 mm2, error bars 
indicate standard deviation): indicated by the amount of leukocytes present throughout the aneurysm dome at 0, 30, and 90 
days in areas 1 through 3 and a comparison of the amount of inflammation elicited by suture materials used to create the 
aneurysm model. Area 1 represents the perimeter of the aneurysm excluding the areas proximal to sutures. Area 2 represents 
the area between the periphery and the core. Area 3 represents the core, or middle of the aneurysm dome. A score of 0 
indicated a lack of leukocytes present in the area evaluated. A score of 1 indicated minimal or one to two leukocytes per area 
evaluated. A score of 2 indicated three to four leukocytes per area evaluated. A score of 3 indicated five to eight leukocytes per 
area evaluated. A score of 4 indicated eight to 11 leukocytes per area evaluated. A score of 5 indicated more than 12 
leukocytes per area evaluated. Silk was not visible in the 0 day time point. 
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points. Inflammation around the suture material was evident [Fig. 
7(C.30,D.30,C.90,D.90)], reflected by an abundance of multinucleated giant cells when 
compared to the foam [Fig. 7(B.30,B.90)].  
2.4.3.6 Healing throughout the aneurysm dome based on neovascularization 
Figure 8 summarizes the amount neovascularization throughout the aneurysm 
domes by quantifying the amount of neovascularization at three locations from the 
periphery to the core. It was shown that at 0 days there was no neovascularization, at 30 
days there was approximately one neovascular bud per area evaluated (Fig. 8), and at 90 
days there was approximately two neovascular buds per area evaluated. 
2.4.4 Neointima proliferation at the base of the aneurysms 
The fourth row of Table 1 summarizes the amount of neointima proliferation at 
the neck of the aneurysm as determined via LV-SEM and histology. At 0 day, there is no 
narrowing of the parent vessel lumen due to a lack of neointima formation [Fig. 2(B.0)]. 
There was approximately 5% narrowing of the parent vessel at 30 days, and for two 
aneurysms, there was between 5 and 20% narrowing [Fig. 2(B.30)]. At 90 days, there 
was <5% narrowing of the parent vessel for all aneurysms [Fig. 2(B.90)]. 
 
 
 
 
 
 
Figure 7: Suture interaction figure. Suture interaction in vivo (2x and 8x magnification): (A.30) 2x H&E staining of a bisected 
aneurysm exhibiting the foam and suture interaction after 30 days of implantation, (B.30) 8x H&E staining of a middle section 
of a bisected aneurysm after 30 days of implantation showing the foam-body interaction, (C.30) 8x H&E staining of suture 
interaction after 30 days of implantation. Diamond indicates polypropylene suture and doughnut indicates focal mineralization 
adjacent to the polypropylene suture material. (D.30) 8x H&E staining of suture interaction after 30 days of implantation. 
Diamond indicates silk suture (A.90) 2x H&E staining of a bisected aneurysm after 90 days of implantation, (B.90) 8x H&E 
staining of a middle section of a bisected aneurysm after 90 days of implantation showing the foam–body interaction, (C.90) 
8x H&E staining of suture interaction after 90 days of implantation. Diamond indicates polypropylene suture and doughnut 
indicates focal mineralization adjacent to the polypropylene suture material, and (D.90) 8x H&E staining of suture interaction 
after 90 days of implantation. Diamond indicates silk suture. 
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Figure 8: Neovascular bud figure. Average pathology scoring of neovascularization throughout the aneurysm dome at 0, 30, 
and 90 days in areas 1 through 3 (250x magnification, or 0.025 mm2, error bars indicate standard deviation): area 1 represents 
the perimeter of the aneurysm excluding the areas proximal to sutures. Area 2 represents the area between the periphery and 
the core. Area 3 represents the core, or middle of the aneurysm dome. A score of 0 indicated no neovascular buds present per 
area evaluated. A score of 1 indicated minimal or one neovascular bud per area evaluated. A score of 2 indicated two to three 
neovascular buds per area evaluated. A score of 3 indicated four to five neovascular buds per area evaluated. A score of 4 
indicated more than five neovascular buds per area evaluated. Black square indicates neovascular bud. 
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2.5 Discussion   
The goals of this research study were twofold: (1) to assess whether 
polyurethane-based SMP foam is biocompatible in vivo when implanted into a porcine 
vein pouch aneurysm model and (2) to demonstrate the feasibility of these materials as 
aneurysm filling devices. These devices were evaluated at three time points, 0, 30, and 
90 days. LV-SEM imaging and histology were performed for all aneurysms.  Histology 
verified that the SMP foams are biocompatible and effective at providing a biological 
scaffold which seems to enhance the healing response as exhibited by presence of a 
predominantly connective tissue substrate within the foam at 90 days. Healing was also 
evidenced by neointima formation across the aneurysm neck, permanently excluding the 
aneurysm from the parent vessel, without compromise of the parent vessel lumen.   
 We have also shown using an internal control that the SMP foam has a reduced 
inflammatory response when compared to conventional suture materials (monofilament 
polypropylene and braided silk). Karaca et al.52 showed that silk and polypropylene 
suture promote granulomatous inflammatory response with varying severity. 
Inflammation noted around these suture materials consisted of a “purulent core 
surrounded by inflammatory cells and an outer fibrous encapsulation.”52 These results 
are similar to those of Chu et al.,19 who noted that in less than 1 month silk and 
polypropylene elicit a marked and moderate reaction, respectively. When implanted for 
up to 24 months, silk and polypropylene, such as were used during creation of the 
aneurysms in the model used for this study, elicit moderate and slight reactions 
respectively, similar to the findings at 90 days in this study.19 The fibrous encapsulation 
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of the foreign material is the hallmark of the end of inflammation induced by a 
material.19 This encapsulation isolates the device/material from the surrounding tissues.19  
When an implanted material induces a minimal or mild inflammatory response 
the connective tissue capsule is smaller and may even be nonexistent.19 When directly 
comparing the SMP foam to the braided silk and to some extent the polypropylene 
sutures, the perimeter of biological tissues surrounding our SMP foam shows a thinner 
capsule and showed less inflammation than the suture used in this procedure as an 
internal control (Fig. 7). The SMP foam induces less chronic-active inflammatory 
response when compared to silk. Whether or not an implant causes a sustained 
inflammatory response is dependent upon the host response to the implanted material.19 
For implanted devices, the physical and chemical properties of the device should ideally 
cause a host inflammatory response that is minimal to mild and of short duration, an 
indicator of biocompatibility. A chronic or chronic-active inflammatory reaction can 
lead to impairment of the function of the tissue in which the implant is located.19 The 
mild inflammatory response seen with the SMP foam in this study leads to an earlier 
transition toward healing, evident by the laying down of collagen and elastin throughout 
the aneurysm and a reduced population of multinucleated giant cells. Transition to 
healing was also present in the areas where sutures were used, but as compared to the 
SMP foam, there was a greater cellular inflammatory response.   
Granulation tissue (early stage of healing) was present throughout the volume of 
the SMP foam-filled aneurysm dome. In general, granulation tissue was comprised of 
collagen, neovascular buds, a small number of macrophages and/or multinucleated giant 
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cells, and, to a lesser extent, eosinophils and neutrophils,19 which was seen with these 
implants. In the later stages of healing, type III collagen is predominant.19 This fibrous 
connective tissue substrate with minimal inflammatory cells is the final transition to the 
host/biomaterial stable state.19   
Neovascular bud infiltration throughout the SMP foam was also evaluated. The 
presence of neovascularization indicates an active healing process, or the intermediate 
step before full encapsulation. In the current study, by 90 days there was an increased 
number of neovascular buds. Similar results were reported after 6 months in a study of 
polyglycolic acid/lactic acid copolymer coated platinum aneurysm coils (Matrix coils, 
Boston Scientific Neurovascular, Fremont, CA; now Stryker Neurovascular).88 These 
results suggested that polymers could promote the healing process to a greater degree 
than bare metal coils when implanted in aneurysms.88 Another study conducted by 
Kipshidze et al.,54 compared a cylindrical reticulated polycarbonate polyurethane based, 
non-SMP foam (vascular occlusion device; Biomerix, New York, NY), to stainless steel 
metal coils. They showed that intravascular implantation of the foams resulted in faster 
and safer aneurysm occlusion.54 Both of these previous studies support the use of 
polymers to promote healing, achieve occlusion, and stabilize aneurysms in vivo. A 
head-to-head comparison of bare platinum coils to these polyurethane SMP foams within 
an aneurysm model would be required in order to make conclusive statements about 
biocompatibility, which would include aneurysm occlusion, healing and stabilization.   
Compaction of coils within a treated aneurysm is a well documented 
phenomenon, particularly in the setting of larger aneurysms and lower packing density, 
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and this compaction results in recanalization of the aneurysm, with varying degrees of 
filling and potential risk of rupture. There was no visual compaction of foam throughout 
our study, and within 90 days, neointima formed over the neck of the aneurysm, 
excluding the aneurysm from the circulation. There was also no gross or microscopic 
evidence of active thrombogenesis at the endothelialized neck, which implies that the 
foam is stable and not affected by blood flow. Previously, it has been proposed that 
aneurysm recurrence40 is facilitated by compaction of the coils4 within the aneurysm sac 
due to the constant impingement by arterial blood flow and/or the lack of complete 
filling during treatment.68 Compaction of metal coils occurs due to the fact that there has 
not been neointima formation over the coils at the aneurysm neck or tissue ingrowth 
from the dome and periphery of the aneurysm; this lack of stabilization and healing is 
most likely due to the lack of biological activity of the platinum coils.  
In conclusion, we achieved both goals introduced in the beginning of the 
discussion. First, we demonstrated that polyurethane-based SMP foam is a 
biocompatible aneurysm filling device when implanted into a porcine vein pouch 
aneurysm model. Second, these initial pathological results demonstrate the feasibility of 
these materials as aneurysm filling devices for clinical application. This was concluded 
based on their biocompatibility demonstrated at 90-day pathological results and 
complete endothelial cap at the base of the aneurysm. Additionally, the ability of these 
materials to be compressed to dimensions that allow them to be delivered via catheter 
also demonstrated feasibility as being developed into a clinical aneurysm filling device. 
While speculative, we believe that aneurysm filling by polyurethane based SMP foams 
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have the potential to be a superior endovascular aneurysm treatment when compared to 
bare metal coils based on the positive pathological results demonstrated by this study.  
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3. OPACIFICATION OF SHAPE MEMORY POLYMER FOAM DESIGNED FOR 
TREATMENT OF INTRACRANIAL ANEURYSMS*2 
 
3.1 Overview 
Shape memory polymer (SMP) foam possesses structural and mechanical 
characteristics that make them very promising as an alternative treatment for intracranial 
aneurysms. Our SMP foams have low densities, with porosities as high as 98.8%; 
favorable for catheter delivery and aneurysm filling, but unfavorable for attenuating x-
rays. This lack of contrast impedes the progression of this material becoming a viable 
medical device. This paper reports on increasing radio-opacity by incorporating a high-Z 
element, tungsten particulate filler to attenuate x-rays, while conserving similar physical 
properties of the original non-opacified SMP foams. The minimal amount of tungsten for 
visibility was determined and subsequently incorporated into SMP foams, which were 
then fabricated into samples of increasing thicknesses. These samples were imaged 
through a pig’s skull to demonstrate radio-opacity in situ. Quantification of the increase 
in image contrast was performed via image processing methods and standard curves 
were made for varying concentrations of tungsten doped solid and foam SMP. 4% by 
volume loading of tungsten incorporated into our SMP foams has proven to be an 
                                                
* Reprinted with permission from “Opacification of shape memory polymer foam 
designed for treatment of intracranial aneurysms” by Jennifer N. Rodriguez, Ya-Jen Yu, 
Matthew W. Miller, Thomas S. Wilson, Jonathan Hartman, Fred J. Clubb, Brandon 
Gentry and Duncan J. Maitland, 2012. Annals of Biomedical Engineering, Volume 40, 
pages 883-897, Copyright 2012 Springer, License Number: 3345431146003. 
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effective method for improving radio-opacity of this material while maintaining the 
mechanical, physical and chemical properties of the original formulation.    
3.2 Introduction 
Cerebral aneurysms are localized dilations of an artery wall in the vasculature of 
the brain, are unstable in structure due to thinning of the arterial wall, and are thus prone 
to rupture.55 Aneurysm rupture into the subarachnoid space occurs in approximately 10 
per 100,000 people in the United States annually23,56 with the majority of people ending 
up dead or severely debilitated.23 Approximately 3–5% of the general population is 
thought to have cerebral aneurysms.23,92 Due to the high mortality and morbidity 
associated with rupture, early and effective treatment of an intracranial aneurysm prior to 
rupture can increase a person’s survival rate and quality of life.23  
The two most common FDA-approved treatments treating cerebral vascular 
aneurysms involve isolation of the weakened portion of vessel via surgical clipping62 
and endovascular embolization through the use of flexible platinum coils. Surgical 
clipping involves a craniotomy, an invasive surgery of the brain, which carries serious 
inherent risks to the patient. Furthermore, surgical clipping is not always possible due to 
an inaccessible location of the aneurysm within the brain or the patient being a high risk 
candidate for surgery due to age or associated medical conditions. As a result of these 
limitations on surgical clipping, endovascular treatment has become an increasingly 
attractive option. The coils are introduced to the aneurysm endovascularly via a 
microcatheter. This filling treatment involves isolation of the weakened area of artery 
from the rest of the vasculature, ideally resulting in the regrowth of the endothelium, the 
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innermost layer of the artery over the entry point or ‘‘neck’’ of the aneurysm. Further, 
this endovascular treatment is not perfect in avoiding aneurysm rupture and subsequent 
hemorrhage, but they have been shown to be superior to clipping in both ruptured and 
unruptured aneurysms.12 ,41,47,62  
While being the favored treatment for intracranial aneurysms, coils do have 
drawbacks, such as the possibility of coil compaction and subsequent formation of new 
side aneurysms adjacent to the original aneurysm,40,100 low packing volume (less than 
50% of the total aneurysm volume45,49,68 leading to recanalizationor refilling,38 migration 
of loose coils into the parent artery,96 and although uncommon, potential puncture of the 
aneurysm dome during coil placement.26 Additionally, coils are not very successful at 
treating aneurysms with neck diameters greater than 4 mm.68 In these large neck 
aneurysms, approximately one-third of coil treated aneurysms either rebleed or 
recanalize.30,63,75,89 It has also been shown that endothelialization at the base of the 
aneurysm is limited due to low endothelial cell adhesion on the platinumsurface.50 
Therefore, although coil treatment is the preferred filling method by interventionalists, 
there is still room for improvement in terms of the safety and efficacy of these devices. 
The drawbacks of the commonly accepted treatments have spurred development 
of alternative aneurysm filling methods. Some of these technologies include treatment 
with multiple commercial devices,42 hydrogel polymer,38 collagen based coils,50 hybrid 
metal and hydrogel coils,1 shape memory polymer (SMP) coils 39 and polymer 
foams.68,86,98 ,99  Previously, it has been proposed by Hampikian et al.,39 that radiopaque 
SMP coils be used to fill aneurysms. This paper focuses on SMP foams as an aneurysm 
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filling method.25,68,87 In theory, the foam provides a scaffold for clotting in a large sub-
volume of the aneurysm that may have advantages over coils.3,60 SMP foams are soft, 
compliant materials that have the ability to be fabricated into essentially any shape. This 
initial geometry can then be deformed by raising the temperature of the material above 
its transition temperature and applying a force. Continuing to apply force while cooling 
below its transition temperature programs the material into a secondary, temporary 
shape. The SMP foam would remain in its temporary shape until it is again heated above 
its transition temperature. For the purposes of aneurysm treatment, a foam of a given 
size and shape matching that of the aneurysm would be crimped onto a delivery device, 
directed into the aneurysm, and then deployed using either an external energy source or 
the body temperature of the patient.   
These SMP foams are polyurethane based97 and have favorable 
biocompatibility.15 One drawback, however, is that these polymer foams have no 
inherent radio-opacity and are not visible using conventional patient imaging modalities 
(e.g., fluoroscopy). This limitation would reduce the likelihood of clinical use as without 
the ability to visualize it, the material could not be delivered safely.8 The first aim of this 
research was to address this lack of radio-opacity, and develop SMP foams that 
exhibited radio-opaque characteristics using standard imaging and superimposition of 
bony and soft tissue structures, with the intention of advancing the clinical application of 
this technology.  
To increase the radio-opacity of our SMP foam, tungsten was added to the 
polymer matrix prior to curing. To minimize the change in the material properties, it was 
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essential to use the smallest amount of tungsten possible that still provided adequate 
opacity. Mechanical, chemical and physical properties before and after the addition of 
contrast agent were compared to determine the effects of adding this opacifying agent to 
the SMP foam. The properties tested include tensile strength, and glass transition 
temperature. In addition to mechanical, chemical and physical properties, 
biocompatibility was also evaluated with a pilot study of one animal consisting of two 
vein pouch aneurysms with an implantation time of 90 days.   
3.3 Materials and methods 
3.3.1 Neat shape memory polymer sample preparation: determination of minimal 
amount of contrast agent necessary for visibility  
Solid, otherwise known as neat SMP material, was used to determine the 
minimum amount of contrast necessary to create a visible change in fluoroscopic 
imaging of the SMP material. Fine tungsten powder, <1 micometer in diameter based on 
manufacturer specifications (Alfa Asear, Ward Hill, MA), was added in varying 
concentrations to neat SMP, and the materials were then cut into samples of increasing 
thicknesses. These samples were placed on top of a porcine head used to mimic the 
density of a human skull, and were imaged fluoroscopically to determine the minimum 
material thickness and the lowest concentration necessary for the polymer to be visible. 
 3.3.2 Solid polymer fabrication   
Neat network polyurethane SMP samples were fabricated based on a variation of 
a composition specified by Wilson et al.97 in 2007, using stoichiometric ratios of polyol 
and diisocyanate monomers. Triethanolamine was added in a 2.0% excess (by mass). 
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N,N,N',N'-Tetrakis(2-hydroxypropyl)ethylenediamine (HPED, 98%) (TCI America, 
Portland, OR), triethanolamine (TEA ≥ 99.5%) (Sigma-Aldrich Co., St. Louis, MO) and 
hexamethylene diisocyanate (HDI, 98%) (TCI America, Portland, OR) were decanted in 
a precise basic controlled atmosphere glove box (LabConco Corporation, Kansas City, 
Missouri) under a dry air atmosphere into glass jars and were subsequently sealed. The 
monomer-containing jars were then removed from the glove box and transferred to a 
vacuum oven, loosely opened for degassing, and degassed for 36 h at 45 C at 1 Torr. At 
the end of the degassing cycle, the monomer containers were re-sealed and transferred 
back to the glove box. The appropriate masses for 0.5, 1.0, 2.0 and 4.0% by volume of 
tungsten powder (<1 lm particle size, 99.95% purity) (Alpha Aesar, Ward Hill, MA) 
were measured out and placed into 60 mL maximum volume mixing containers 
(FlackTekTM, Inc. Landrum, SC) which were then transferred to the glove box. The 
purge/fill cycle of the glove box was run for at least 5 cycles prior to transferring 
monomers into their respective containers.   
The alcohol monomers, 0.4 mol of HPED and 0.19 mol of TEA, were added to 
the containers with the appropriate amount of tungsten, sealed tightly and then removed 
from the glove box. The 1.00 mol of HDI monomer, stored in a desiccator until use, was 
then added to the containers in the fume hood. After combining all of the monomers and 
tungsten, the containers were mixed for 2 min at 2400 rpm using the DAC 150 speed 
mixer (FlackTek TM, Inc. Landrum, SC).   
A volume of 3 mL of the mixture was transferred to 5 mL lurelock syringes. This 
volume was chosen such that the stoppers had ample room to move during degassing 
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without separating from the syringe. The syringes, with a cap tightly secured on the tip, 
were put into a sonicator for 1.5 min. The exterior of the syringes were dried, the caps 
loosened, and then they were placed in a bell jar for 1.5 min under vacuum. The samples 
were removed from the bell jar, caps retightened, and the sonication step was repeated 
for 1.5 min. After sonication, the syringe caps were punctured with a needle and placed 
back into the bell jar for another 20 min under vacuum. The samples were initially held 
at room temperature for 2 h, and then the temperature was increased at a rate of 30 º C/h 
120 º C was reached, at which point the temperature was held constant for 1 h prior to 
slow cooling to room temperature. 
3.3.3 Solid sample preparation   
Use of 5 mL syringes as casting molds resulted in 12.3 mm diameter cylinders of 
polymer doped with the varying amounts of tungsten (0.5, 1.0, 2.0 and 4.0%). These 
cylinders were then cut to thicknesses of 0.25, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, 
5.0, 6.0, 7.0, 8.0, 9.0 and 10.0 mm by an IsoMet 11-1280-160 saw (Buehler, Lake Bluff, 
Illinois). One control of 0% tungsten SMP polymer was cut into a 10.0 mm sample.    
3.3.4 Multiple samples mounted in one holder: preliminary imaging  
Samples of increasing thicknesses of 0.5, 1.0, 2.0 and 4.0% tungsten-doped SMP 
were mounted in and acrylic holder, one for each concentration, etched by a LS100 laser 
cutter (Gravograph, Duluth, GA) to allow for ease of imaging in one frame (Fig. 9). 
3.3.4 Samples mounted separately: quantitative imaging   
Neat samples of all concentrations and increasing thicknesses were individually 
mounted into acrylic holders that were laser etched by a LS100 laser cutter. Each acrylic  
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Figure 9: Increasing thicknesses of 0.5, 1.0, and 4.0% tungsten doped neat polymer 
samples mounted in an acrylic holder, samples imaged via fluoroscopy at TIPS. 
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sample holder was identified by radio-opaque markers that indicated concentration and 
sample height (Fig. 10b). 
3.3.5 Determination of minimal polymer loading by fluoroscopic imaging  
The neat polymer samples with a pig (Fig. 9) were imaged at the Texas Institute 
for Preclinical Studies (TIPS) at Texas A&M University, using an AlluraXper FD20 
(Philips Healthcare, Andover, MA) fixed fluoroscope. Single image plane images were 
acquired at a rate of 3 frames per second, with an exposure of 22 mAs, using Allura 
Xper 7.2.1 software, with the voltage potential set to 70 kV. The source to detector, and 
source to sample distances were set to 1195 and 810 mm respectively for all samples. 
All samples were imaged using these power settings for the remaining imaging sessions 
of this paper. Each of the samples, mounted in their respective holder, was imaged to 
show the relative increase in contrast observed for each set of samples for each 
concentration.    
3.3.6 Qualitative radio-opacity of SMP foam preparation 
Polyurethane SMP foam samples were prepared with the same monomers as the 
neat polymer samples, using HDI, HPED and TEA. These monomers were premixed 
forming an isocyanate prepolymer and stored in a desiccator for 42 h prior to being 
mixed with the alcohol premix, catalysts and surfactants. The isocyanate prepolymers 
were foamed by adding alcohol premix (TEA), catalysts and surfactants (DC-5179, DC-
I990, T131, BL-22 (Air Products and Chemicals, Inc, Allentown, PA)) and blowing 
agents (DI water and Enovate (Honeywell International Inc., Morristown, NJ)), and then  
 
 
 
 
Figure 10: Controlled sample positioning imaging setup. (a) external holder to secure the sample to the pig’s head in the same 
position in all images, (b) sample holder mounted inside of the external holder, top number is the concentration of tungsten, 
and the bottom number is the thickness in mm, (c) background image consisting of the pig’s skull and the external holder, (d) 
sample image consisting of the pig’s skull, external holder and sample. 
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mixed by a DAC 150 speed mixer for 15 s at 3400 rpm. An overall NCO/OH ratio of 
1.05 was used for foaming. The foams were cured at 90 C under vacuum for 12 h. 
Both the SMP foam and tungsten-doped SMP foam were made in a similar 
manner. The 4% by volume tungsten foam was made by adding 28.978 g of tungsten to 
the isocyanate premix and mixed for 30 s in the DAC 150 speed mixer at 3400 rpm. The 
alcohol premix was then added, and mixed for another 15 s at 3400 rpm. A volume of 3 
mL of blowing agent (Enovate) was added to the mixture, and was allowed to vent while 
mixed for another 15 s at 3400 rpm. While the foam began to raise it was then allowed to 
sit at room temperature for 5 min prior to being placed in a 90 º C preheated oven. To 
support the cell structure as it cured, a vacuum was gradually pulled. After 1 h, the 
temperature was allowed to gradually decrease to room temperature; however, the 
vacuum remained on while the foam cured overnight.    
3.3.7 Foam sample preparation 
Cylinders of foam, 12 mm in diameter, were cut using biopsy punches. Samples 
of 0 and 4% tungsten doped foams were cut to be eight times the sample height of the 
neat polymer samples, which resulted in cylinders with heights of 2, 4, 8, 12, 16, 20, 24, 
28, 32, 36, and 40 mm (Fig. 11a).    
3.3.8 Multiple foam samples mounted in one holder: preliminary imaging 
Foam cylinders of increasing heights, made of both the 0 and 4% tungsten foams, 
were mounted in acrylic holders similar to the solid samples (Fig. 11a), that were laser 
etched by a LS100 laser cutter.    
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3.3.9 Foam samples mounted separately: quantitative imaging   
Samples of the same concentration and heights used in the preliminary imaging 
step were also individually mounted into acrylic holders that were laser etched by a 
LS100 laser cutter and individually identified by radio-opaque tags that indicated 
concentration and sample height (Fig. 10b).    
3.3.10 Qualitative determination of radio-opacity of SMP foams via fluoroscopic 
imaging 
The samples of 0 and 4% tungsten foams that were mounted in their respective 
acrylic holder were imaged using via fluoroscope, using the same settings as before, both 
with a pig’s skull thickness (Figs. 11b, 11c) and alone next to a radiographic standard 
(Figs. 11d–3f).    
3.3.11 Radio-opacity of crimped SMP foams 
Multiple diameters of biopsy punches, 6, 8, 10 and 12 mm, were used to make 
cylindrical tungsten-doped samples of foam. These samples were crimped radially, 
parallel to the central axis, to their minimum diameter with a ST150-42 stent crimper 
(Machine Solutions Inc.TM, Flagstaff, Arizona), at 100 degrees C, and allowed to cool 
to room temperature for 2 h. Crimped samples were imaged through the crimped 
cylinder thickness using a fluoroscope, with a pig’s skull and tissue, next to a 
microcatheter to observe their relative radio-opacity (Figs. 12a–12b).    
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Figure 11: Fluoroscopic imaging of SMP foam with pig skull thickness. (a) profile view 
of 0 and 4% tungsten-doped SMP foam samples, (b) control 0% tungsten-doped SMP 
foam device with increasing thicknesses from 2 to 40 mm imaged via fluoroscopy with a 
pig’s skull thickness, (c) 4% tungstendoped SMP foam device with increasing 
thicknesses from 2 to 40 mm imaged via fluoroscopy with a pig’s skull thickness, (d) 
control 0% tungsten-doped SMP foam device with increasing thicknesses from 2 to 40 
mm imaged via fluoroscopy, (e) 4% tungsten-doped SMP foam device with increasing 
thicknesses from 2 to 40 mm imaged via fluoroscopy, (f) aluminum standard. 
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Figure 12: Fluoroscopic imaging of crimped SMP foam. (a) mechanically crimped 4% 
tungsten-doped SMP foam imaged via fluoroscopy, original diameters: 6, 8, 10 and 12 
mm with a pig’s skull thickness next to a catheter with radio-opaque platinum bands, (b) 
mechanically crimped 4% tungsten doped SMP foam imaged via fluoroscopy, original 
diameters: 6, 8, 10 and 12 mm next to the same catheter as in 4A. Thicknesses from 2 to 
40 mm imaged via fluoroscopy, (e) 4% tungsten-doped SMP foam device with 
increasing thicknesses from 2 to 40 mm imaged via fluoroscopy, (f) aluminum standard. 
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3.3.12 Quantification of image contrast of solid SMP and foams 
A stationary external acrylic mount was laser etched by a LS100 laser cutter to 
ensure proper positioning of the individually mounted samples while being imaged (Fig. 
10a). The individually mounted samples of solid SMP and foam were imaged using a 
fluoroscope by securing the external holder to the pig’s head, and imaging each sample 
down the center of its cylindrical geometry, as seen in Fig. 10d, to quantify the increase 
in image contrast as material thickness increased. Additionally, images with the external 
holder secured to the head without a sample were obtained as the background images; 
the background image representing the contrast obtained from a pig’s head (Fig. 10c).    
The original fluoroscopic images acquired were converted from Digital Imaging 
and Communications in Medicine (DICOM) to 8 bit Tagged Image File Format (TIFF) 
format and imported into Matlab R2008a (MathWorks, Natick, MA), where they were 
processed using the Image Processing Toolbox. Each image, originally 512 x 512 pixels 
in dimension, with a resolution of 0.439 mm/pixel, including an averaged background 
image, were cropped to a 15 x 15 pixel, equivalent to 6.6 mm x 6.6 mm image (Figs. 
10c– 10d)—a region well within the area (120 mm2 for neat samples and 110 mm2 for 
foam samples) of the sample portion within the image. Using the cropped images, the 
sample images were subtracted from the background image. The difference in contrast 
was determined for each pixel from the 15 x 15 pixel images.    
3.3.13 Differential scanning calorimetry 
Differential Scanning Calorimetry was performed on all samples using a Q200 
(TA Instruments, New Castle, DE), using a heat-cool-heat cycle (an initial ramp of 20 º 
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C/min up to 150 º C, held isothermal for 2 min, then ramped down to 240 º C at a rate of 
20 º C/min, held isothermal for 2 min, and then ramped back up to 150 º C at a rate of 20 
º C/min) detailed by Wilson et al.97 Six samples were run at each concentration for all 
neat SMP and foam concentrations.    
3.3.14 Mechanical testing 
Stress/strain behavior of the 0 and 4% by volume tungsten-doped foams were 
determined via strain to failure experiments using an Insight 30 material tester (Materials 
Testing Solutions MTS Systems Corporation, Eden Prairie, MN). Due to fabrication 
methods of our foams, sample size was limited to 60 mm x 15 mm x 6 mm. Following 
the ASTM D638-Standard Test Method for Tensile Properties, ten samples of each 
concentration were tested utilizing a speed for non-rigid samples at a constant strain rate 
of 50 mm/ min at room temperature.2   
3.3.15 Scanning electron microscopy 
Foam samples were dried in an oven preheated to 90 C for12 h under vacuum. 
SEM analysis was carried out on foam blocks of 5 mm x 5 mm x 5 mm in dimension. 
The foam samples were secured to the holder using double-sided carbon tape that were 
then sputter-coated with gold and palladium to increase the conductivity and to prevent 
charge build-up of the electrons absorbed by the specimen. The morphology of the foam 
samples were analyzed using a Quanta 600 field emission scanning electron microscope 
(FEI, Hillsboro, Oregon).    
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 3.3.16 Porcine implants of 4% tungsten-doped foams  
 4% tungsten-doped SMP block of foam was machined into two 12 mm spherical 
samples using a MDX-540 Roland 3D Mill (Roland DGA Corporation, Irvine, 
California). These samples were cleaned and sterilized via ethylene oxide to prepare 
them for implantation. A porcine animal model previously reported by Guglielmi in 
1994,36 was utilized to simulate in vivo aneurysm conditions for histological evaluation 
and healing of 4% tungsten-doped SMP foam. This model is constructed by the use of a 
harvested vein segment, in which one end of the segment is sewn onto an opening 
created on the carotid artery, with the opposite end tied off at the apex to create a 
pouch.36 These samples were implanted into the aneurysms located on both the left and 
right carotids. The implanted materials remained 90 days within the aneurysms prior to 
sacrifice.    
Vessels were harvested, fixed via formalin, and both pathology and SEM were 
performed to analyze healing. Histology of the vessels included embedding of tissues in 
paraffin, and serial sectioning of the aneurysm domes. For microatomic histological 
evaluation, or presence of cells associated with inflammation, hematoxylin and eosin 
(H&E) was used to stain the tissues; this staining elucidates the nuclear structures by 
staining them blue, and all other eosinophilic structures pink or orange. Masson’s 
trichrome and Phosphotungstic acid haematoxylin (PTAH) was used to evaluate 
connective tissues, such as fibrin and collagen. Trichrome dyes erythrocytes orange, cell 
cytoplasm red and collagen fibers blue. PTAH stains collagen fibers reddish pink and 
fibrin fibers blue. Three serial sections of the aneurysms were evaluated: proximal to the 
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aneurysm orifice, middle aneurysm dome and apex of the dome. Overall healing for all 
areas was reported; magnifications evaluated were 3.5, 4, 10 and 20x. The initial gross 
results demonstrated in Fig. 10b, and the morphology of the lesion were verified and 
evaluated by SEM imaging of the same area (Fig. 10c).     
This work was approved by and performed in accordance with guidelines of the 
Texas Institute for Preclinical Studies, and Texas A&M University’s (Institutional 
Animal Use and Care Committee, IACUC), and that it adheres to the Guide in the Care 
and Use of Laboratory Animals established by the US National Academy of Sciences (or 
guidelines that insure equivalent or higher standards of care).    
3.4 Results 
3.4.1 Determination of minimal tungsten loading of polymer via fluoroscopy imaging 
Thicknesses of solid SMP samples mounted in acrylic holders were imaged 
fluoroscopically superimposed on a pig head to determine minimal percentage of 
tungsten loading that could be seen in thin samples (~1 mm). Neat polymer samples cut 
from all concentrations (0.5, 1.0, 2.0 and 4.0%) tungsten were imaged, as seen in Fig. 9. 
This set of images indicated 4% tungsten samples were able to produce clearly defined 
regions of contrast, and poorly defined regions of increased contrast were observed by 
samples made from the lower concentrations. It was determined that 4% tungsten by 
volume loading would be sufficient for the doped foam samples for the remainder of the 
experiment.    
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3.4.2 Qualitative determination of radio-opacity of SMP foams via fluoroscopic imaging 
3.4.2.1 Expanded foams 
All of the 0% tungsten foams (Figs. 11b, 11d) were not visible when imaged via 
fluoroscopy, both superimposed with a pig’s skull and alone, next to the radiographic 
standard. The 4% tungsten-doped aneurysm foams imaged (Figs. 11c, 11e) were visible 
at thicknesses greater than 8 mm when superimposed with a pig’s skull. When imaged 
without being superimposed with a pig’s skull, the 4% tungsten foams of all thicknesses 
greater than 2 mm were visible when imaged next to the radiographic standard. The 
image contrast obtained by 40 mm of 4% tungsten-doped foam was measured to be 
equivalent to 1 cm thickness of aluminum (Figs. 11e, 11f).    
3.4.2.2 Crimped foams 
Crimped 4% tungsten-doped SMP foams (6, 8, 10 and 12 mm original diameter) 
were made and imaged via fluoroscopy with a pig and next to a catheter and a 
radiographic standard (Figs. 12a–12b). When imaged without the pig’s skull thickness, 
the crimped samples (6, 8, 10 and 12 mm original diameter) exhibit contrast levels 
similar to aluminum between 2 and 4 cm thicknesses respectively, when compared to the 
radiographic standard (Fig. 12b). The crimped foams were superimposed on the pig skull 
(Fig. 12a), demonstrating visibility for devices with an original thickness of at least 6 
mm and increasing visibility with increasing original diameter, or material thickness.   
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3.4.2.3 Quantification of image contrast of solid SMP and foams 
Samples from 0.5, 1.0, 2.0 and 4.0% tungsten-doped neat polymer, 0 and 4% 
tungsten-doped SMP foam were imaged using fluoroscopy in the same position, 
positioned by the external stationary holder (Fig. 10a) secured to the top of a pig’s skull 
as seen in Fig. 10d. Raw data was acquired in DICOM format, converted to TIFF format 
where each individual sample image was subtracted from a background image, and data 
was plotted as difference in contrast vs. polymer thickness, as seen in Fig. 13 for solid 
polymer samples, Fig. 14 for foam samples. Figure 13 quantifies the increased contrast 
obtained from the solid polymer samples superimposed on the pig’s head. The observed 
increase in contrast obtained from all thicknesses of control SMP foams as seen in Fig. 
11b is not visible to the human eye. As seen in Fig. 11c, foams greater than 8 mm show 
up on fluoroscopic images; indicating that increase in contrast obtained by these samples 
are visible to the eye. Figure 14 compares the percentage of increase in image contrast 
vs. sample thickness for 0 and 4% tungsten-doped foams.  
3.4.3 Differential scanning calorimetry   
The differential scanning calorimetry data for all materials observed in this study 
is summarized in Fig. 16, where inflection point data for six samples per concentration is 
reported. The 0 and 4% tungsten foam samples had average glass transition temperatures 
of 83.4 and 83.4 º C, high glass transition temperatures of 85.3 and 85.7 º C and low 
glass transition temperatures of 81.1 and 82.2 º C, respectively. Solid polymer samples 
exhibited an average glass transition of 62.5 º C, and an overall range of glass transitions 
within 11.5 º C for all samples measured (Fig. 16).  
 
 
 
Figure 13: Percentage of increase in contrast obtained by neat polymer samples. 
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Figure 14: Percentage of increase in contrast obtained by SMP foam samples. 
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3.4.4  Mechanical testing   
A summary of the mechanical results were tabulated in Table 3. Breaking tensile 
strength increased in the 4% tungsten-doped foams when compared to the 0% tungsten 
foams. Breaking strain increased in the 4% doped tungsten foams when compared to the 
control (0% tungsten foams). On average, the doped foams exhibited an increase in 
Young’s moduli; the 4% tungsten-doped foams exhibited a Young’s modulus of 1670 ± 
548, and the 0% tungsten, or control foams, exhibited a Young’s modulus of 1170 ± 406. 
Figure 15 is a representative stress strain curve for 0 and 4% tungsten-doped foams. The 
elastic behavior of these materials is represented by the linear region exhibited at strains 
less than 5%. There was an average increase in the modulus by 43% of the 4% tungsten-
doped foams compared to the control foams. 
3.4.5 Scanning electron microscopy 
Figures 17a–17c are Scanning Electron Microscopy (SEM) images of 0 and 4% 
SMP foams. Figure 17a is a 40x magnification SEM image of the control (0% tungsten) 
SMP foam showing pore cell diameters roughly around 600 micrometers. In Fig. 17b, 
4% tungsten doped foam is shown at 40x magnification, and in this image, pore cells are 
shown to be heterogeneous, roughly ranging from 250 to 800 micrometers in diameter. 
Figure 17c is a 250x magnification SEM image of a 4% tungsten-doped foam sample, 
which exhibited the <1 micrometer diameter tungsten particles dispersed within the 
polymer matrix. 
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Table 3: Summary of mechanical property results.
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Figure 15: Representative stress strain curve of tensile testing of 0 and 4% tungsten 
foams. 
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Figure 16: Glass transition data for solid SMP and SMP foam, n = 6 per concentration. 
 
 
 
Figure 17: Scanning electron microscopy of control and 4% tungsten foams. (a) SEM micrograph of control SMP foam (40x 
magnification), (b) SEM micrograph of 4% tungsten SMP foam (40x magnification), and (c) SEM micrograph of 4% tungsten 
SMP foam (250x magnification). 
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3.4.6 Porcine implants of 4% tungsten-doped foams   
3.4.6.1 SEM of lumen of artery at foam artery interface 
Figure 18 summarizes the SEM and pathological results from implanting 4% 
tungsten foams within a vein pouch porcine aneurysm model for 90 days. Figures 18a, 
10b and 10c are representative of the healing response at the gross and microscopic 
scales. The left carotid aneurysm model failed due to vasospasm during implantation, 
which caused the artery to collapse on itself, and thereby eliminating patency of the 
parent artery. Due to a lack of blood flow interaction with the parent vessel, SEM 
imaging was not performed on the left carotid aneurysm. The right carotid remained 
patent throughout the 90 days of implantation, and the aneurysm/artery interface was 
imaged via SEM at 100x magnification at 15 kV. SEM imaging of the right carotid 
showed that there was complete covering of the exposed foam with endothelial cells 
aligned parallel to the arterial blood flow, the surface exhibited a lack of mural thrombi, 
and complete healing of the aneurysm lesion was observed. Macroscopically there is an 
evident presence of endothelial cells at the aneurysm and artery interface after 90 days 
(Fig. 18b). Additionally in Fig. 18c, the endothelial cells were mature and aligned to 
blood flow. 
3.4.6.2 Pathology 
Both carotid aneurysms were evaluated via histology. The left and right 
aneurysms were both composed of 75% connective tissue, and had minimal lumen 
narrowing (<5%) with respect to the neointima proliferation. More than 95% of the inner 
core of the aneurysms had been infiltrated by dense cellular connective tissue with 
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regards to the healing that took place at the anastomosis interface, central core, and outer 
distal edge of the aneurysm dome. Inflammation of the central core and outer edge was 
minimal for both of the aneurysms; having less than 5% of the regions infiltrated by 
inflammatory cells. 
Figure 18d is a hematoxylin and eosin stain (H&E) cross-section of bisected 
artery and aneurysm sac (4x magnification). The presence of blue stained nuclei helped 
determine the amount of multinucleated giant cells; an abundance of such cells indicates 
inflammation. However, as is shown in Fig. 18d, there are minimal amounts of 
multinucleated giant cells surrounding polymer struts, indicating a contained healing 
response within the dome of the aneurysm. For both aneurysms, less than 5% of the 
volume was filled with fibrin, and there was greater than 90% of collagen throughout the 
aneurysm (Fig. 18e). Additionally, in Fig. 18e, is a Trichrome cross-section of bisected 
aneurysm sac (4x magnification). It is shown in Fig. 18e that significant healing has 
occurred within 90 days, represented by blue stained collagen throughout the dome of 
the aneurysm, and minimal presence of red blood cell residuals. Figure 18f is a 
Phosphotungstic acid–hematoxylin (PTAH) cross-section of bisected artery and 
aneurysm sac (3.5x magnification). It is shown in Fig. 18f that there is more than 90% 
deposition of collagen, and less than 5% residual fibrin throughout the dome of the 
aneurysm. Figures 18h and 18i are histological details of the amount of inflammation 
present around suture materials, polypropylene and silk respectively. There were 
multifocal areas of mild chronic inflammatory cells proximal to the areas of suture 
material (Figs. 18h, 18i). These areas show a granulomatous inflammatory cell response  
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Figure 18: SEM and pathology results of implanted foams. (a) gross picture of dissected 
aneurysm and parent vessel, (b) gross picture of healing that took place between 
aneurysm and parent artery intersection (en face), (c) SEM of endothelial cell 
morphology across the ostium (100x magnification), (d) H&E cross-section of bisected 
artery and aneurysm sac (4x magnification), (e) trichrome cross section of bisected 
aneurysm sac (4x magnification), (f) PTAH cross-section of bisected artery and 
aneurysm sac (3.5x magnification), (g) H&E Cross-section of bisected artery and 
aneurysm sac (20x magnification), (h) H&E detail of the FDA approved suture material, 
polypropylene, indicated by the black arrow (10x magnification), and (i) H&E detail of 
the FDA approved suture material, silk, indicated by the black arrow (40x 
magnification). 
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to the suture materials represented by densely packed cells indicated by purple 
stained nuclei (Figs. 18h, 18i). When comparing the 4% tungsten-doped foam (Fig. 18g) 
to the silk and polypropylene suture materials, there is significantly less inflammation 
around the implanted polymer material (Figs. 18h, 18i).    
3.5 Discussion 
The goal of this research was to determine the minimal amount of tungsten 
necessary to make SMP foam visible when imaged via standard clinical imaging 
methods. Creating cylindrical neat polymer samples doped with increasing 
concentrations (0.5, 1, 2 and 4% by volume) cut into samples of increasing thicknesses 
facilitated the plotting of a standard curve for each concentration to be made. Visibility 
of the 4% tungsten neat samples at 1 mm thickness demonstrated the feasibility of 
achieving clinically practical radio-opacity in the 4% tungsten-doped foams. This 
assumption was based on an expected 80x expansion ratio of neat polymer to foam, and 
the subsequent conclusion that approximately 1 mm thickness of tungsten doped neat 
polymer and 8 mm thickness of 4% tungsten-doped SMP foam contained relatively the 
same amount of tungsten. In previous research performed by Hampikian et al.39, 3% by 
volume doping of tantalum in SMP was successful at qualitatively creating visible X-ray 
contrast via fluoroscopy imaging at material thicknesses of down to 0.088 mm through 
water, which is consistent of our results. However, they did not perform imaging through 
bone and soft tissues, nor did they quantify the amount of contrast they achieved with 
3% doping of their SMP.39 
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In order to quantify the degree of contrast at different concentrations of tungsten 
for both neat and foam SMP samples, the difference in pixel intensity from the 
background image was calculated for each of the samples. It was observed that when a 
sample of sufficient thickness increased image contrast, or darkened the image, by 
approximately 8% (Weber contrast) for an 8-Bit image, they were visible through the 
skull and associated soft tissues. The 0% tungsten (control) SMP foam of all heights was 
determined to increase the contrast by approximately 5% (Weber contrast95) over 
background in both the images taken with the skull thickness and when imaged alone, 
remained unidentifiable by visual inspection. By doping the SMP foam with 4% by 
volume of tungsten powder, it was determined that foam was visible at a thickness 
greater than 8 mm when superimposed with the skull and tissues, which was the case 
when there was an increase in the contrast by more than 8% by the sample (Weber 
contrast95).  
Our proposed SMP aneurysm filling device consists of foam that would be 
crimped to its minimum diameter for delivery, and remain in this temporary state until it 
had been navigated into an aneurysm, at which point it would be actuated by heat to fill 
the sac. It was demonstrated that visibility of a crimped 4% tungsten-doped foam, 
original diameter of 6 mm (Fig. 12) was accomplished, and the increase in contrast 
observed by all of the crimped samples were approximately equal to 2–4 cm of 
aluminum when compared to the radio-opaque standard (Fig. 12b). The crimped samples 
exhibited a 25, 30, 33 and 37% increase in contrast for 6, 8, 10 and 12 mm original 
diameter samples respectively (Figs. 12a, 12b). Creating contrast by crimped foams of 
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these diameters was a significant step toward clinical application, as the average size of 
berry aneurysms is approximately 8 mm in diameter, and the imaging used in this study 
was the same as would be employed in a clinical setting. Although the 4% tungsten 
doped 6 mm SMP foam was visible in the crimped state, the sample may not be visible 
when expanded in vivo. Clinically, this may not be an issue due to the similarities to the 
current clinical situation during endovascular treatment of aneurysms, in which the 
unsatisfactory or satisfactory nature of the embolization is defined by the presence or 
absence of filling of the aneurysm by blood (injected contrast dye), rather than by the 
appearance of the coils themselves.   
An additional goal of this research was to determine if the addition of tungsten 
powder to the matrix of the polymer would greatly alter the transition temperature of our 
foams. For all the 24 neat polymer samples the average glass transition was 62.5 ± 3.9 
degrees C (Avg ± Std. Dev.). Among the 12 foam samples measured the average was 
83.6 degrees C, and the standard deviation was 1.3 degrees C. The addition of particulate 
tungsten powder at a concentration of 4% by volume did not significantly alter the glass 
transition of the foam material, and therefore, acted as an inert filler material. These 
results coincide with the previously published study by Cui et al.22, in which they 
demonstrated that the addition of particulate BaSO4 up to 40% by weight into 
polyurethane based SMP did not greatly affect the polymer matrix. Differential scanning 
calorimetry data showed that there was more variation of the glass transition 
temperatures among the neat polymer samples however; all samples in all concentrations 
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and polymer forms were within approximately 10 degrees C of each other, indicating 
that the tungsten filler had little effect on the polymer matrix during fabrication.    
The mechanical properties of the ten samples tested of each 0% (control) and 4% 
tungsten-doped SMP foams are summarized in Table 3. The addition of 4% tungsten to 
the SMP foam increased its breaking tensile strength, breaking strain, and Young’s 
modulus by 67, 60, and 43%, respectively. Previously, it has been shown by Gibson and 
Goods that there is a relationship between increases in cell density and an increase in the 
modulus of foam material,34,35 which may have been the case with the 4% tungsten-
doped foams in our study. It was observed that the 4% tungsten-doped foams exhibited 
greater cell density than the 0% tungsten non-doped foams. Additionally, in 2002 and 
2004, Gall et al.31,32 have demonstrated that the addition of a filler into SMP can increase 
modulus, and strength. More specifically related to foam materials, Saha,82 reported that 
the addition of nanoparticle filler materials to polyurethane foams increased the tensile 
strength and the modulus. Our material, also being based off of polyurethane chemistry, 
may be exhibiting similar mechanical behaviors.    
Figures 17b and 17c are SEM images of the two concentrations of SMP foams 
tested. These figures are examples of the cell structures in both concentrations. From the 
SEM images, it is evident that the cell size and cell density of 0 and 4% tungsten-doped 
SMP foams are different. The 4% tungsten foam sample exhibited a higher cell density 
and appeared to be more heterogeneous in pore cell size, including smaller pore cell 
sizes than that of 0% tungsten SMP foams, which suggests that the <1 micrometer 
dispersed tungsten particles act as heterogeneous nucleation sites during cell 
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formation.16,66,82 Figure 17c shows the tungsten particles dispersed into the matrix of the 
polymer. These particles are potentially acting as points of stabilization throughout the 
material, thereby increasing the toughness of the foam, which is also exhibited by the 
mechanical testing (Fig. 15). Heterogeneity was seen in the tungsten-doped foams by the 
increased range in pore cell sizes exhibited in the SEM images.    
Pathological results show that there was minimal inflammation (<5% fibrin 
deposition and less than 5% inflammatory cell infiltration) within the aneurysm dome. 
These results are all indicative that the tungsten doped SMP is a biocompatible filling 
material for the treatment of aneurysms.   
Relative to the addition of tungsten to the SMP, the risk of tungsten toxicity for 
tungsten coils has been addressed. Peuster et al.72 showed that slow degradation of 
tungsten coils emit small amounts (29 microgram/day) of tungsten in the vasculature and 
is not toxic in vitro which has been validated clinically by the lack of toxicity to tungsten 
coils in patients. Note that we use much less tungsten in our foams (0.2 g for typical 8 
mm foam sphere) than the average coils used by Kampmann et al.51 and Saatci et al.81 
(12 g per coil, for a 0.25 mm DIA and 12.5 mm length of mechanically detachable spiral 
tungsten coils (MDSs)) and an average of 5 coils inserted per aneurysm. In Fig. 18g, a 
20x magnification detail of the aneurysm dome, it is shown that the tungsten particulate 
is encapsulated within SMP, preventing it from leaching out at a fast rate in vivo. If 
leaching is present, it should be at such a slow rate that it would not be toxic to the 
patient, given that the material has remained intact for a time frame of 90 days in vivo. 
This previous research performed by Peuster et al.72 and this research support tungsten 
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doped polyurethane based SMP foams as a viable alternative filling material for treating 
intracranial aneurysms.   
This research sought to accomplish multiple goals in the process of the 
development of a SMP foam aneurysm-filling device. The first requirement addressed 
was the opacification of the SMP foam which would allow for visualization during 
endovascular treatments using standard imaging (fluoroscopy) while being 
superimposed with bony and soft tissue structures (imaging through a pig head), and we 
have demonstrated this. The second requirement addressed was that the mechanical 
properties of the opacified foam be similar, or better when compared to the original 
formulation of SMP foam. This second requirement was met when the foam was doped 
with 4% by volume tungsten particulate. The tungsten-doped foam not only maintained 
its integrity, but also exhibited an increase in its modulus based on the results of the 
stress to failure mechanical testing. The third requirement addressed related to the 
chemical properties of the material, which required that the addition of tungsten 
particulate not significantly change the transition temperature, for this material the glass 
transition temperature. The tight grouping of glass transition temperatures exhibited by 
the 0% (control) and 4% tungsten foams supports the success of this goal. The fourth 
requirement was that the 4% tungsten-doped SMP materials should not have a 
significantly higher inflammatory response in vivo when compared to FDA approved 
materials. This fourth requirement was met by the almost complete healing of the 
aneurysm site after 90 days, and the lack of inflammation when compared to the suture 
material. These results provide a significant advancement for these materials to be 
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developed into aneurysms filling devices for clinical use. Further study is warranted; 
including more thorough biocompatibility tests of the 4% tungsten-doped SMP material 
in vivo and eventually clinical trials. This research serves as a foundation to support 
these future endeavors. 
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4. RETICULATION OF LOW DENSITY SHAPE MEMORY POLYMER FOAM FOR 
VASCULAR OCCLUSION 
 
4.1 Overview 
Predominantly closed-cell low-density shape memory polymer (SMP) foam was 
recently reported to be an effective aneurysm-filling device in a porcine model 
(Rodriguez et al., Journal of Biomedical Materials Research Part A 2013: 
(http://dx.doi.org/10.1002/jbm.a.34782)). Because healing involved blood clotting and 
cell migration throughout the foam volume, a more open-cell structure may further 
enhance the healing response. This research sought to develop a non-destructive 
reticulation process for this SMP foam to disrupt the membranes between pore cells. 
Non-destructive mechanical reticulation was achieved using a gravity-driven floating 
nitinol pin array coupled with vibratory agitation of the foam and supplemental chemical 
etching. Reticulation resulted in a reduced elastic modulus, but did not impede shape 
memory behavior. Reticulated foams were capable of achieving rapid vascular occlusion 
in an in vivo porcine model.  
4.2 Introduction 
 An intracranial aneurysm, or abnormal bulging of an artery wall within the 
brain, is susceptible to rupture, having a great potential to result in mental debilitation or 
death.7 Rupture of an aneurysm, or sub-arachnoid hemorrhage, results in bleeding out 
into the spaces of the brain. The cause of aneurysm growth and rupture is not fully 
known, but is thought to be due to abnormal blood flow patterns, local shear stresses and 
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the weakened state of the arterial wall.17 Due to the inability to predict the occurrence of 
a rupture of such a malformation, and its potential to have a mortal or harmful outcome, 
it is advantageous for the patient to be treated as early in the disease progression as 
possible.  
 In the past couple of decades, endovascular treatment has become the preferred 
treatment versus surgical methods. This is mainly due to the significantly less invasive 
nature of endovascular treatments, which includes reduced recovery time and cost when 
compared to surgical craniotomy. Previously, it has been shown that polyurethane based 
shape memory polymer (SMP) foam is a biocompatible material for the purpose of 
aneurysm filling77, 79 in a porcine animal model. Additionally, other non-shape memory 
polymeric polyurethane and polycarbonate foams have been explored for the purpose of 
vascular54 and abdominal aortic aneurysm76 occlusion with promising results. In this 
research we sought to develop a self-actuating vascular occlusion device (VOD) made of 
SMP foam to be delivered via endovascular methods. 
 It has been shown by Singhal, et al., in 2012, that polyurethane based SMP 
formulations can be tailored to be blown into foams with various actuation temperatures, 
densities and pore cell sizes.85 These ultra-low density SMP materials have the ability to 
be temporarily programmed to a secondary compressed shape and maintain that shape 
until the material’s temperature is elevated above its transition temperature. Around the 
transition temperature, the material regains its original shape. This ability to maintain a 
compressed shape until exposed to an increase in temperature above its transition 
temperature makes these materials excellent candidates for endovascular applications. 
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Given their shape memory capability, tunable pore cell size, tunable actuation 
temperature and proven biocompatibility77, we desire to develop these materials as an 
endovascularly delivered VOD.  
These foams possess a predominantly closed cell microstructure, which may not 
be optimal for aneurysm occlusion and subsequent healing. Post processing to reticulate 
the foam, or remove/puncture the thin membranes between pore cells while leaving the 
net-like foam backbone intact33, will likely enable blood flow to more easily permeate 
throughout the foam, and allow for a forming clot to stabilize the device within the 
aneurysm. This permeation of blood throughout the material also enables the desired 
cellular components necessary to induce healing to more easily migrate into the volume 
of foam after clotting has occurred.  
Reticulation has been achieved by multiple post-processing methods within 
industry, including caustic leaching33 via exposure of the foam to a caustic bath for a 
specific amount of time, temperature and speed, thermal reticulation via a controlled 
burning of the membranes with the ignition of hydrogen and oxygen gases within a 
vessel housing the foam, or cyclic loading and unloading of the material. The act of 
reticulation changes the overall physical properties of foam. In general, it has been 
shown that with the removal of membranes there is a decrease in the resistance to 
mechanical compression.9 There is also an increase in tensile properties, such as 
elongation and tearing strength.9 When developing a reticulation procedure for SMP 
foam, care must be taken to avoid damaging the foam struts to preserve shape memory 
behavior and minimize the impact on its mechanical properties. 
  77 
This research sought to develop a methodology for reticulation of membranes 
between the pores of SMP foam without damaging the native structure9 or shape 
memory ability, with the intent of using these processed materials as a VOD. A viable 
non-destructive method of reticulation was developed involving mechanical membrane 
puncture and supplemental chemical etching, and the effect of reticulation on the 
mechanical properties of the foam was determined. To demonstrate proof of concept for 
these materials as a VOD, the occlusion time was determined via catheter implantation 
of reticulated foam devices within the vasculature of a porcine animal model. This 
research may accelerate the process of development of these materials as VODs for 
aneurysm treatment or other vascular applications aimed at achieving hemostasis.   
4.3 Materials and methods 
4.3.1 Foam synthesis 
Two versions of SMP foam were fabricated by the method described by Singhal 
et al., in 2012 and 2013.84,85 One version contained 100% Hexamethylene diisocyanate 
(HDI) and the other contained 20% HDI and 80% Trimethyl-1,6-Hexamethylene 
diisocyanate (TMHDI) for the isocyanate monomer in the polyurethane reaction. The 
less hydrophobic 100% HDI foam was made specifically for vessel implantation studies 
to allow for immediate self-actuation of the VOD in vivo without the need for external 
heating. The foam actuates at body temperature after exposure to moisture in the blood 
which causes a drop in the material’s transition temperature. The other formulation was 
used for development of the reticulation system and mechanical testing. Both foams 
were reticulated and chemically post-processed in the same manner. Aside from their 
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different hydrophobicities, these two foams share very similar mechanical properties and 
shape memory characteristics.84 During the foaming process, the material is constrained 
by the side walls of the container and unconstrained from above as it rises. Due to these 
conditions and their ultra-low densities9, the foams have an anisotropic morphology as 
demonstrated in Figure 19.  
4.3.2 Nitinol wire characterization 
 Nitinol wire pins were chosen as the means of mechanically reticulating the 
foam. Straight drawn nitinol wire (0.008” diameter) was purchased from Nitinol Devices 
& Components, Inc. (Fremont, CA), and was tested via strain to failure according to 
ASTM F2516 – 07 Standard Test Method for Tension Testing of Nickel-Titanium 
Superelastic Materials. Tests were performed on six samples using an Instron 5965 load 
frame (Instron©, Norwood, MA) equipped with a 500 N load cell. The Young’s modulus 
and buckling load (critical load at which a column bows outward) of the nitinol wire 
were calculated. Young’s modulus was calculated as the ratio of true stress to true strain  
at low strain. The buckling load was determined from the Euler column formula   
Fcr = (π 2 EI)/(KL)2     
 
where Fcr is the minimal buckling load, K accounts for the end conditions, E is the 
Young’s modulus, L is the length of the column and I is the area moment of inertia for 
the cross section of a cylindrical column, a circle, given by   
I = (π/4)R4  
 
where R is the radius of the column. The end conditions, K, are determined as follows: 
both ends fixed: K = 0.5, one end fixed, one end pivots: K =0.707, both ends pivot: K = 
 
 
 
Figure 19: SEM cross-section images of native SMP foam in (a) horizontal (x-y) and (b) vertical (x-z) planes. The cells are 
elongated in the direction of the foam rise (z, vertical). The membranes between cells are evident. 
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1, one end fixed, one end free: K = 2. Since the end of the nitinol pin is free to move 
laterally when interacting with the foam surfaces, K was taken to be 2.   
4.3.3 Mechanical reticulation system 
The mechanical reticulation system consisted of two main components: (1) a 
gravity-driven floating nitinol pin array and (2) a vertically oscillating vibratory shaker 
upon which the foam was mounted for reticulation (Figure 20A). Each pin was made by 
casting a nitinol wire in a 1 ml syringe filled with EpoxAcast® 690 (Smooth-On, Inc., 
Easton, PA) doped with < 1 µm tungsten particulate (Alfa Aesar, Ward Hill, MA). A 50-
mm length of nitinol protruded from the cast polymer cylinder (Figure 20B). The pins 
were loaded perpendicular to the top surface of the foam in individual channels drilled in 
a delrin block. The low-friction channels allowed unrestricted vertical motion of the 
pins. The pins were spaced 7 mm apart in a radial pattern. With the free ends of the 
floating nitinol pins in contact with the foam, the foam was agitated (0.25 mm 
amplitude) by the vertically oscillating shaker (Fritsch, Analysette 3 Spartan pulverisette 
0), allowing for gravity-driven downward movement of the pins. Agitation continued 
until the pins penetrated the full thickness of the foam. The delrin block, which was 
chucked into a Bridgeport milling machine (Hardinge Inc., Elmira, NY) for controlled 
step wise movement, was then translated horizontally (pins removed) for further 
reticulation of the foam sample. Samples were punched in a raster manner every 500 
µm.  The samples were punched in one axis (uni-axial) or three axes (tri-axial). Uni-
axial reticulated samples were punched along the direction of foam rise only (z-axis).  
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Figure 20: Mechanical reticulation system setup. (a) mechanical reticulation system 
including the floating nitinol pin array and vibratory foam shaker. (b) close up of the 
array punching the foam. (c) nitinol pins cast in non-doped (left pin) and tungsten-doped 
polymer (right pin). 
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Tri-axial reticulated samples were punched along the x-, y-, and z-axes by punching 
along one axis, re-orienting the foam, and punching along a different axis.    
4.3.4 Preliminary mechanical reticulation testing  
 To determine the pin mass necessary to puncture a 30-mm-thick foam sample 
using the mechanical reticulation system, pins of variable mass were made by varying 
the amount of tungsten in the cast pins. Pins were made with masses of 0.25, 0.5, 0.75, 
1.0, 1.5, 2.0, 2.5 and 3.0 grams.  Uni-axial reticulation was performed to assess the effect 
of pin mass.    
In addition to the method of varying the pin mass using the reticulation system, 
the membrane strength (minimal force necessary to puncture a membrane) and the 
friction of a wire passing through the foam were determined via mechanical testing using 
the Instron load frame equipped with a 50 N load cell.  Agitation of the foam was not 
employed in these tests. A custom grip incorporating a pin vise was used to hold the 
0.008” nitinol wire perpendicular to the foam sample. The wire extended 50 mm beyond 
the grip. All measurements were taken at ambient temperature. The force necessary to 
puncture a single membrane was determined in both the axial (foam rise) and trans-axial 
(orthogonal to foam rise) directions to assess potential differences due to the anisotropic 
foam cell structure. The force necessary to puncture a membrane was determined as the 
first spike in force prior to a sharp decrease in force encountered within the first 2 mm of 
foam. This distance was chosen due to the average pore cell size being roughly 1 mm in 
diameter. Force spikes greater than 10 g were likely caused by direct interaction with a 
strut, not a membrane, and were ignored. One hundred and fifty four (154) 
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measurements in the axial direction and 153 measurements in the trans-axial direction 
were made. For measurement of friction between the nitinol wire and the foam as it 
penetrated through the 30-mm-thick foam, the crosshead was translated at a rate of 1 
mm/min while the load was recorded. Two separate measurements were made. The 
friction is reported as the slope of the load vs. extension data, excluding the spikes where 
the nitinol wire tip directly contacted a membrane or strut. 
4.3.5 Chemical etching and final cleaning 
In specified cases mechanical reticulation was supplemented by chemical etching 
to assess the effect of more thorough membrane removal as opposed to membrane 
puncture. To attempt to remove residual membranes after mechanical reticulation the 
foams were immersed into a 5N NaOH solution for 30 minutes while sonicated using a 
5510R-DTH and 3510R-DTH ultrasonic cleaner (Branson® Ultrasonics Corp., Danbury, 
CT). The samples were then repeatedly rinsed with RO water to neutralize the samples. 
All samples (etched or not) were finally cleaned using the protocol outlined by 
Rodriguez et al. in 2013.78 The samples were then dried for approximately three hours 
under vacuum at 90 ºC.    
4.3.6 Imaging foam microstructure    
Dried foam samples were sputter coated with gold using a Cressington 108 
sputter coater, model 6002-8 (Ted Pella, Inc., Redding, CA) for 60 seconds at a distance 
of 3 cm. Imaging of the SMP foam was done before and after reticulation via low 
vacuum scanning electron microscopy (LV-SEM) using a NeoScope JCM-5000 (Jeol 
USA, Inc., Peabody, MA). 
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4.3.7 Mechanical characterization of foam  
Mechanical testing of SMP foam was performed in compression mode according 
to ASTM D1621 – 10 Standard Test Method for Compressive Properties of Rigid 
Cellular Plastics using the Instron load frame with a 500N load cell. Cylindrical samples 
25.4 mm in diameter by 25.4 mm tall of both the non-reticulated and reticulated 
(chemically etched or not etched) foams were prepared. These samples were frozen in a -
80 ºC freezer overnight and subsequently lyophilized for 24 hours prior to mechanical 
testing. To assess the effects of pin mass, uni-axial vs. tri-axial reticulation, and chemical 
etching, nine different reticulation schemes (including a non-reticulated control) were 
investigated as outlined in Table 4. Five (5) samples were tested for each scheme.    
4.3.8 In vivo vascular occlusion assessment  
Uni-axial and tri-axial reticulated SMP foam samples were cut into 20-30 mm 
long cylindrical samples using a 10mm diameter biopsy punch.  The samples were pre-
conditioned by radially compressing to 1 mm diameter using a SC250 stent crimper 
(Machine Solutions Inc®, Flagstaff, AZ) at 97 °C and heated to expand to their original 
shape.  The SMP foam cylinders were then chemically etched, rinsed, and cleaned.  The 
samples were dried in vacuum and stored in an air-tight container with desiccant.  The 
cylindrical samples were cut to 8 mm diameter using fine-tip scissors and 10 mm long 
using a razor blade.  Samples were then radially compressed to the minimum diameter of 
approximately 1 mm using the stent crimper at 97 °C, cooled under compression to 
maintain the compressed shape, and stored in an air-tight container with desiccant until 
implantation in vivo.    
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Six (6) devices (3 uni-axial and 3 tri-axial reticulated using 1 g pins) were successfully 
deployed into multiple hind limb vessels of a three month old, 25 kg pig. Angiography 
performed prior to implantation of the VODs indicated the diameters of the vessels were 
on average 2.6 mm in diameter, which was smaller than the 8-mm diameter of the 
uncompressed VODs; therefore, the devices were able to expand to approximately 33% 
of their original diameter. A 5F catheter, 0.055” inner diameter, was navigated to the 
implant site using a 0.035” guidewire. The compressed foam VOD was submerged in 
room temperature saline for 2-5 minutes and then submerged in 32 °C saline for 3-5 
seconds.  The device was placed inside the catheter for 5 minutes to allow the foam to 
begin expanding and then pushed out of the catheter using the 0.035” guidewire (Figure 
21A-C). This procedure resulted in expansion of the foam immediately as it emerged out 
of the catheter as shown in a preliminary bench top in vitro demonstration (Figure 21D-
F). Contrast enhanced fluoroscopy was used to determine when the device had been 
deployed, by observing the location of the guide wire and if possible a lack of contrast 
agent in the vessel. After delivery into the vessel, the device expanded to its primary 
shape and subsequently blocked the vessel. We defined vessel occlusion time as the time 
after device delivery until injected contrast agent ceased to flow through or past the 
device; at that point clotting is likely to have occurred. Vessel occlusion time was 
determined via iodinated contrast injections visualized with angiography 45 seconds 
after deployment and then at 30 second intervals thereafter.54Average occlusion times 
were reported.      
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Figure 21: Schematic diagram of endovascular deployment of the SMP foam VOD. (a) 
the device is pushed near the 5F catheter tip by the guidewire, (b) the guidewire pushes 
the self-actuating device out of the catheter, and (c) the deployed device fills the vessel 
lumen. (d-f) in vitro demonstration of VOD deployment showing immediate expansion 
of the VOD in 37°C (body temperature) water in a silicone tube (3.5 mm inner 
diameter). 
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4.4 Results   
4.4.1 Nitinol pin properties  
From the six samples tested it was determined that the average Young’s modulus 
of the nitinol wire was 58.62 ± 0.93 GPa. From this data, the buckling load for different 
pin lengths was calculated (Figure 22). The buckling load for the 50-mm-long nitinol 
pins is estimated to be 0.5 g.    
4.4.2 Mechanical reticulation 
Results of varying the mass of the pins showed that there is a range of masses 
that increase the number of punctured membranes throughout the foam thickness as seen 
in Figure 23. This range is between 0.75- 2 grams when reticulated in the axial direction 
of the foam.   
The average and median mechanical force to puncture a single membrane was 
determined to be 2.07 ± 2.23 grams and 1.27 grams in the axial direction and 1.13 ± 1.09 
grams and 0.80 grams in the trans-axial direction respectively (Figure 24A). Due to the 
range of measurements, large standard deviation and overlapping data a Wilcoxon Mann 
test was used to evaluate the difference between the two data sets. The Wilcoxon Mann 
test resulted in a P_TwoTail value of 0.00252858, which indicated that the two data sets 
were not the same. Buckling of the nitinol pins may occur based on these measurements, 
which could influence the reticulation path (and, hence, the number of punctured 
membranes) as they penetrate through the foam. Friction during penetration though the  
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Figure 22: Calculated buckling load of 0.008” diameter nitinol wire. 
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Figure 23: Results of axial reticulation through 30 mm of SMP foam using pins with 
different masses. An increase in reticulation was observed for pin masses of 0.75-2 
grams. 
 
 
 
Figure 24: Membrane strength and friction interaction. (a) membrane strength for the axial and trans axial orientations and 
(b) frictional force experienced between the nitinol wire and SMP foam as it penetrated through a 30 mm thickness of foam 
in the axial direction. 
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foam was estimated to be 0.12 g/mm  (Figure 24B). The spikes in the data are 
interactions between the nitinol tip and either a membrane or a strut of the SMP foam, 
and were intentionally ignored for the friction estimate. However, the spikes generally 
exceeded the estimated buckling load of the nitinol pins, further suggesting that buckling 
can occur during reticulation.    
4.4.3 Effect of reticulation of foam mechanical properties  
The foams reticulated according to Table 4 are shown in Figure 25. As shown in 
Figure 26, the non-reticulated control foam had an average elastic modulus of 
approximately 2.65 X 105 Pa. Reticulation reduced the modulus, with the tri-axial 
reticulated foams having the lowest moduli. The more extensive disruption of the cell 
membranes caused by reticulation in multiple axes resulted in higher reduction of the 
modulus. Closer inspection of the data shows that chemical etching of the uni-axial 
reticulated foam increased the modulus, while the tri-axial reticulated foams showed a 
slight decrease in modulus after chemical etching. In both the axial and tri-axial cases, 
the modulus was higher when 2 gram pins were used for axial reticulation compared to 
the use of 1 g pins. Figure 27 is a summary of the average stress versus strain curves for 
the 5 samples tested per case. Following the trend in modulus, the non-reticulated foam 
had the highest stress plateau before densification, followed by the uni-axial and finally 
the tri-axial reticulated foams.    
 
 
 
 
 
Table 4: Reticulation schemes employed for mechanical testing of foams.
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Figure 25: Scanning electron microscopy (10X magnification, scale bar = 2 mm) of 
reticulated foam samples that were later mechanically tested. The cases are summarized 
in table 1. 
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Figure 26: Elastic moduli for the foams reticulated according to table 1. 
95 
 
 
Figure 27: Average compressive engineering stress vs. engineering strain for the foams 
reticulated according to table 1. 
  96 
4.4.4 In vivo vascular occlusion  
The uni-axial reticulated foam had an average occlusion time of 90 ± 11s and the 
tri-axial reticulated foam had an average occlusion time of 128 ± 77s. Figure 28 
illustrates VOD deployment and subsequent vascular occlusion of a tri-axially 
reticulated VOD.  Figure 29 shows angiograms of all treated vessels before VOD 
implantation and after vessel occlusion. On average the uni-axial reticulated foam 
induced faster occlusion that the tri-axial reticulated foam. This result is not unexpected 
since blood flow is likely impeded more by the less reticulated foam, potentially 
resulting in more rapid clotting. However, the large deviation of the occlusion time for 
the tri-axial reticulated foams, as well as the 30-s interval between contrast injections, 
prevents reaching a definitive conclusion on the effect of extent of reticulation on 
occlusion time; further study is required.     
4.5 Discussion   
 Previously we have demonstrated that our SMP foams are biocompatible in 
vivo, when implanted into a porcine aneurysm model.77 Though excellent healing was 
observed, these foams possessed a predominantly closed-cell structure, which likely 
limits the amount of blood flow allowed to percolate through the material and may delay 
or inhibit optimal healing in vivo. Reticulation may enhance application of these 
materials as an aneurysm filling or other vascular occlusion device.   
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Figure 28: In vivo deployment of a tri-axial reticulated foam. a) pre-deployment contrast 
enhanced angiography, b) guidewire ejection of the foam from the catheter (no contrast 
used), c-g) contrast enhanced angiograms acquired after deployment at 30-s intervals, h) 
close up view of the fifth contrast enhanced angiography performed after deployment. 
Occlusion is evident in (g) and (h), 165 s after delivery. 
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Figure 29: Angiograms acquired (a) before implantation of the SMP foam VODs and (b) 
after vessel occlusion occurred. A separate angiogram showing the distal portion of one 
of the treated vessels is overlaid in (a). White circles indicate the locations of the SMP 
foam VODs in (b). (c) Compressed vascular occlusion device (scale divisions in mm). 
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We developed a method for non-destructive mechanical reticulation of ultra-low 
density SMP foam by using a gravity-driven floating nitinol pin array coupled with 
vibratory agitation of the foam. Appropriate pin masses and agitation amplitude were 
identified to enable the desired level of reticulation. We focused on mechanical 
reticulation in different axes, versus changing the pin density of the array, to adjust the 
level of reticulation, and investigated chemical etching of the materials post reticulation.   
Overall, mechanical reticulation resulted in a reduced elastic modulus, but did 
not impede shape memory behavior as demonstrated by the in vitro delivery and in vivo 
occlusion tests. The modulus was lower for foams reticulated in multiple axes compared 
to a single axis. Supplemental chemical etching was not mechanically detrimental and 
for the axial cases tended to slightly increase the elastic modulus.  
The reticulated VODs were capable of achieving rapid vascular occlusion in an 
in vivo porcine model, indicating that SMP foam could be used as a device not only to 
fill aneurysms, but to also occlude patent vessels under arterial pressure. It was shown 
that on average the less reticulated the VOD, the faster the occlusion time. However, 
further study is needed to definitively conclude that occlusion time is affected by level of 
reticulation. While we hypothesize that predominantly open-cell foams may enhance the 
aneurysm healing response compared to predominantly closed-cell foams due to the 
increased pathways for blood flow and cell migration, further work must be done to 
assess the healing response of reticulated foams. 
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5. 4D FLOW VISUALIZATION AND POROUS MEDIA PROPERTIES OF 
MECHANICALLY RETICULATED SHAPE MEMORY POLYMER FOAM 
 
5.1 Overview 
Intracranial aneurysms, an unstable dilation of an artery within the brain that are 
prone to rupture. Upon rupture they have debilitating or mortal consequences to the 
patient. We have proposed an alternate endovascular filling method to the currently used 
platinum coils; based on shape memory polyurethane polymeric foams. Promising 
pathological results have resulted from the implants of these materials in vivo at ninety 
days within a porcine animal model. These blown foams are natively closed cell, which 
is not advantageous for proper healing in vivo or for fluid dynamics characterizations. In 
an effort to increase permeability of this porous media we previously developed a 
mechanical reticulation system to disrupt the membranes. These advances in material 
processing and previously reported promising pathological results have increased the 
desire to determine the fluid and foam structure interactions. We have used mechanical 
reticulation and chemical etching to vary the permeability of these materials and 
characterized them.  We have estimated the structure of the blown foams to determine 
surface area, porosity and aspect ratio based on location within the batch. We have 
further imaged flow patterns, via MRI imaging, and have measured the porous media 
properties of these foams in an effort to further understand the physics of the fluid and 
foam. This research is an initial step toward understanding the foam and fluid 
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interactions in vivo and provides a better understanding of the structure of these 
heterogeneous materials. 
5.2 Introduction  
5.2.1 Cerebral aneurysms and subarachnoid hemorrhage 
5.2.1.1 Current treatments and limitations 
The current treatment for intracranial aneurysms involves either platinum 
clipping of the sac or endovascular filling involving mostly platinum coils. Surgical 
clipping involves an invasive craniotomy, with inherent risks of its own, and therefore 
endovascular methods have become the favored option for treatment. Treatment with 
platinum coils involves filling the aneurysm sac via the aide of fluoroscopic imaging. 
Platinum coils are implanted until there is a lack of contrast agent present within the 
dome after an injection is made to the site. This methodology usually results in low 
packing of the dome, but thus far is the standard for implantation. Along with low 
packing density of the aneurysm dome, there are other drawbacks with the use of 
platinum coils to treat these malformations within the brain. 
Platinum coils have the tendency to compact or migrate from the site of 
implantation. These two complications can result in the reformation of sidewall 
aneurysms, recanalization of the original aneurysm, or potential blockage of the parent 
vessel. There also remains the possibility that the platinum coils can puncture the 
unstable dome either during or after treatment, resulting in a catastrophic event. In 
addition to the previously mentioned drawbacks, aneurysms that remain treated also 
have the tendency to remain in constant state of inflammation which never results in 
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healing; such a state would be indicated by a constant cycle of breaking down and 
reforming of an unstable fibrin layer on the platinum coils. With the limitations of the 
currently available treatment methods, we have proposed a polymeric based alternative 
method for filling the aneurysms. Of note, there are other polymer based and hybrid 
devices that are either on the market or are being developed for the treatment of 
aneurysms, however this paper will focus on a polymer based foam treatment.  
5.2.1.2 Proposed treatment of intracranial aneurysms by SMP foams 
We have proposed to treat intracranial aneurysms with shape memory polymer 
foams. These materials are based on polyurethane chemistry, previously reported by 
Singhal, et al.85 They are blown foams that are foamed into closed cell morphology. 
With the aid of mechanical reticulation and caustic etching78, the pores can be 
interconnected for the passage of fluids, such as blood. After processing the material is 
said to be in its permanent shape. These materials have the ability to be programmed into 
a different shape other than their permanent shape, a temporary shape, and remain in this 
condition until they are exposed to a stimulus, which raises their bulk temperature above 
their transition temperature. Programming involves raising the temperature of the 
material above its transition temperature, and then deforming the material by application 
of a force. To finish the programming process the material is constrained in a temporary 
shape while cooling the material below its transition temperature. Once the temperature 
is below the transition temperature the material will remain in this shape. These 
properties along with demonstrated in vivo biocompatibility77at ninety days, make these 
materials ideal for the development of an endovascular aneurysm filling method.     
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5.2.2 Necessity of characterization of SMP foam for prediction of fluid interaction in 
vivo   
The previous implantations of these materials within the porcine aneurysm model 
has demonstrated that these materials induce favorable conditions for healing77 and that 
they promote clotting within minutes of exposure to blood in vivo.78 Therefore, further 
characterizations of these materials through a thorough study of their in vitro fluid 
interactions are advantageous for further understanding of the occlusion process. There 
are multiple factors that may be initiating the clotting process in vivo.  By studying the 
fluid interaction with these porous media, we hope to better elucidate some of the 
processes and form some general knowledge of what is occurring in vivo. For example, 
dwelling time within the foam and shear rates have been shown to affect the clotting 
cascade in vivo. Understanding the porous media properties and fluid dynamics of these 
materials at varying amounts of reticulation may help in the future design of these 
materials as occlusion devices.  
Previously, it has been shown that within an artery of a patient having a basilar 
artery aneurysm, the mean blood velocity in the parent vessel is between 20 and 50 cm/s 
to 10 to 30 cm/s.53 In 2013, Ortega et al., has performed CFD simulations within SMP 
foam treated aneurysms and has shown that velocities within the foam are much lower 
than the previously values reported.70 Due to these findings, we find it necessary to 
quantify permeability and average velocity flows in lower velocity ranges from 0 to 7 
cm/s to better help validate our previous work on simulations. Further validation of 
observing low velocities via permeability and magnetic resonance velocimetry (MRV) 
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comes from previous work performed by Small et al. in 2009. It was shown that the 
velocity of the fluid within the foam increased and was significantly decreased distal to 
the foam when observed via MRV.86  
5.2.3 Permeability  
The previously reported method for mechanical reticulation involved the use of 
individual nitinol pins that were able to penetrate the foam via agitation and gravity. 
These pins were patterned in a matrix that had a set distance of pins, which was used in a 
raster manner to reticulate in one or three axes of the foam. This method enabled the 
amount of reticulation of these foams to be varied. The pin punching density can tune 
the resultant amount of fluid allowed to pass through. This ability for fluids to pass 
through a porous material is called permeability or the pressure drop across the material, 
which can be measured experimentally by varying the velocity of the fluid. Further 
analysis of these foams can estimate the viscous and inertial losses of the pressure drop 
via the Forchheimer-­‐Hazen-­‐Dupuit-­‐Darcy	  (FHDD)	  equation:	  −!"!" = !! !! + !"!!! 
where the pressure gradient,  
!!"!"  , along the sample in the direction of flow (Pa/m), µ is 
the dynamic viscosity of the fluid (Pa · s), K is the intrinsic permeability of the sample 
(m2), !! is the Darcy velocity (flow rate, Q, divided by cross-sectional area of the 
sample) (m/s), ρ is the density of the fluid (kg/m3), and C is the form factor of the 
sample (m-1). When the velocities of the flow are low, at Reynolds numbers less than 1, 
the FHDD equation reduces to the Darcy equation.4	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The Reynolds number can be estimated from the previous equation as: 
     Re  =   
!  !!!"!  
 
which is a ratio of the forces contributed via inertial losses to the losses from the viscous 
forces. 
The friction factor can be determined via non-dimensionalization of the FHDD equation 
by Cρνο2.65 
                 
-­‐dp dxCρνο2 =  f  =   1Re +1 
in which the left hand side of the equation are the calculated terms based off of measured 
values and the right hand side of the equation is the theoretical model for the friction 
factor. Via the Reynolds number and friction factor, data from the experimental results 
of this study can be compared to previous or future data. In addition to the porous media 
properties determined from permeability measurements, it is also possible to visualize 
the flow within these reticulated foams via magnetic resonance imaging (MRI) or more 
specifically magnetic resonance velocimetry (MRV).  
5.2.4 MRV measurements  
Magnetic resonance velocimetry (MRV) is a non-invasive and non-destructive 
method for measuring three dimensional mean velocity components within an object via 
traditional MRI or nuclear magnetic resonance (NMR). These imaging methods can be 
used on complex and opaque models, making this method potentially superior to the 
traditional particle image velocimetry (PIV) method. MRV can be used to measure a 
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one, two or three-dimensional space within a model at a range between 101 and 103 
µm.28 In addition to mean velocities, MRI can be used to measure temperature86, 
velocities of turbulent flow, Reynolds stresses, diffusion coefficients, chemical species, 
and the presence of multiple phases.28 MRV is capable of measuring velocities between 
10 m/s to 1 cm/day, or 1.2 x 10-7 m/s.28 Imaging of one dimensional images takes mere 
minutes to measure, while three dimensional volumes can take a couple of hours, with 
conventional scanners able to image sub millimeter resolution having a diameter of 30 
cm.28   
Previously, MRV imaging was used to measure temperature and mean velocity 
flows within an SMP foam device while it was actuated via laser light heating.86 
However, this data was to observe the actuation of a slightly oversized device (~ 4 mm) 
in small diameter tubing of 2.5 mm for the testing and optimization of medical device 
design using similar materials.  In this paper, we propose to use MRV to further 
characterize SMP foams that have had differing amounts of mechanical reticulation. We 
would like to determine if MRV is a way to visualize and quantify the average velocity 
vectors within SMP foams that are of different formulations and morphology of SMP 
foam as a way to optimize these materials.    
Velocity encoding involves utilizing the local spin magnetization, a vector 
quantity, as a way to measure flow. By obtaining magnitude and phase data from 
velocity encoding gradient acquired MRI imaging, the velocity of a fluid may be 
determined by subtracting the two set of phase images while the magnitude data can be 
used as a mask. Two sets of phase data are acquired during the application of inverted 
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gradients, the usual method for encoding velocity, which results in two image sets with 
different first moments, ΔM1, or M1(1)-M1(2), that are proportional to the amplitude and 
timing of the gradient. Subtraction of the two phase images results in phase differences 
Δ⏀ that are proportional to the velocity of the fluid. By Fourier reconstruction the MRV 
signal is resolved into phase and intensity data as a function of location. The spatial 
velocities are determined by dividing the pixel intensities in the phase difference images 
by !!M, where the velocity sensitivity, or venc, is the maximum velocity.58 The average 
velocity of the fluid is calculated through the following equations: 
ν = Δ⏀/(ϒΔΜ1) = (Δ⏀/ π)*venc  
 venc = π/(ϒΔΜ1)  
 Δ⏀ = ±π  
where v is the velocity (m/s), Δ⏀ is the phase difference, ΔM1 is the difference in the 
first moments, venc is the maximum velocity in m/s and γ is the gyrometric ratio. 
Imaging flow within the foam via clinical imaging methods can be achieved is a pulse 
sequence, 4D Flow, which acquires the difference in phase in X, Y, Z.59 
5.2.5 Significance of these characterizations  
Four samples of SMP foam measurements are capable of acquiring data about 
the fluid flow within a complex model; it provides limited information about pressure.29 
Therefore, permeability measurements via traditional methods are necessary in order to 
determine the form factor (C) and permeability (K) values of a material. Additionally, 
MRV measurements could potentially be used to validate computational fluid dynamics 
(CFD) predictions and the measured permeability along with surface area results can be 
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used to fine tune the current models used to simulate fluid flow through SMP foam.67, 69, 
70 
5.3 Materials and methods 
5.3.1 SMP fabrication  
The foams used for this study were based off of 80TM SMP chemistry reported 
by Singhal, et al., in 2013.84 This foam was mechanically reticulated in a similar manner 
as reported by Rodriguez et al., in 201478, which had a hole punching density of 
approximately 13% per face punched, (12.9717mm²/100 mm2). There were nine cases of 
foam that were made for this study based on different levels of reticulation, or removal 
of membranes between individual pore cells, which are summarized in Table 5.  
5.3.2 Permeability and imaging foam sample fabrication     
These samples were core punched into cylindrical samples that were 
approximately 17 mm in diameter and 20 mm in length parallel to the axis of foaming. 
After mechanical reticulation these samples were affixed into acrylic sample holders that 
were 19 mm OD, 16 mm ID and 30 mm in length, with UV cured medical grade epoxy 
(Dymax Corporation, Torrington, CT). The foam was lined up with the proximal end of 
the sample holder to leave 1 cm open on the distal end and were compressed by 
approximately 9.1% within the sample holder. The acrylic sample holders were 
fashioned with custom silicone gaskets on both ends to ensure flow through the sample 
during measurements. These gaskets were made of 0.015” thick soft silicone rubber with  
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Table 5: Samples prepared for the study. Axial cases gram weight indicates the mass 
used to reticulate in the Z-axis. Tri axial cases list gram weight of the Z-axis reticulation 
first and the Z-X and Z-Y axes second. 
 
 
  110 
a durometer hardness of 20A that were cut to size with a Gravograph LS100, CO2 laser 
etcher (Gravograph, La Chapelle-Saint-Luc, France). These gaskets were then adhered to 
the ends of the sample holders with silicone adhesive.     
Samples were then either cleaned or base etched and cleaned. Cleaning was 
achieved with soap solution consisting of (80:20) RO water and Contrad 70 solution, 
(Decon Labs, Inc., King of Prussia, PA), and agitated via sonication for 30 minutes. 
Base etching was achieved via 5N NaOH solution for 30 minutes with sonication.78 
These different cases are called case 1-9 for the remainder of this paper (Table 5), with 
case 9 being the control group. After processing the samples were then placed in water 
and evacuated in a bell jar eight hours to remove bubbles from the samples. 
5.3.2.1 Foam characterization 
After mechanical reticulation and etching the samples were characterized via 
multiple imaging methods and their porosity, relative density, major diameter, minor 
diameter, aspect ratio, surface are and expansion ratio were estimated based on their 
location within the foam. The nine cases of foam that were characterized in this paper 
were imaged via scanning electron microscopy on a NeoScope JCM-5000 (Jeol USA, 
Inc., Peabody, MA) after the samples were sputter coated with gold using a Cressington 
108 sputter coater, model 6002-8 (Ted Pella, Inc., Redding, CA) for 60 seconds at a 
distance of 3 cm. SEM imaging of the foams allowed for visualization of the amount of 
membrane removal for the nine cases.  Micro computed tomographic (µ-CT) imaging 
was performed using an Xradia scanner, using a 4X objective, set at 50kV, and 5W, and 
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reconstructed by the Xradia Reconstructor having a 5.96 µm/voxel for 800 slices on two 
foam samples.  
Additional characteristics of the foam were also calculated from the density of 
the neat polymer (1.1 g/cm3) and measurements from microscopy images.84 The relative 
density of the foam (ρporous) was calculated from the mass of a known volume of foam. 
The porosity, Θ, of the foam, or void space within the foam, was measured and 
determined via the equation: 
Θ = (ρneat –ρporous)/ ρneat	  
The volume expansion of the foam, or how much the foam can be compressed, was 
determined via the equation: 
                       VE = ρneat/ ρporous 
The aspect ratio was determined via the equation: 
                      AR = Dmajor/Dminor 
where Dmajor is the larger diameter and Dminor is the smaller diameter. Aspect ratio was 
determined after measurements were made from pore cells in different areas of the foam 
via microscopy. These values were used to determine the approximate surface area from 
3 dimensional 12 faced pentagonal and 14 faced hexagonal models. From these 3D 
models surface area and volume of one pore was determined. 
Surface area of the foam was approximated using the following relationships:     
Θ = (ρneat –ρporous)/ ρneat = (Vtotal – Vfoam)/Vtotal 
where  Θ   is the porosity, Vtotal  is the total volume and was assumed to be 1 cm3 and  
Vfoam is the volume taken up by the struts and membranes of the foam. Vfoam was 
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approximated using the following equation: 
Vfoam = Vtotal – (Npores* Vpore)  
where Npores  is the number of pores within 1 cm3 and Vpore is the volume of one pore 
estimated from the 3D models. Npores was approximated using the following equation: 
Npores  = (Θ/Vtotal) / V pore	  Which	  resulted	  in	  the	  following	  equation	  for	  surface	  area: SA  foam = SA pore (⏀/ V pore) 
where SAfoam  is the surface area of the foam and  SA pore is the surface area of one pore. 
Characterization of the structure of the foam by the previous mentioned methods 
allowed for the surface area of the foam based off of location within a batch to be 
estimated. These estimates along with permeability measurements further elucidate the 
foam and fluid interaction necessary for CFD validation and refinement.      
5.3.3 Permeability flow loop     
The nine cases of samples (n = 3 per case) having varying densities were evacuated 
overnight to remove air bubbles from the samples and were then placed within the 
pressure chamber in the flow loop, diagramed in Figure 30. The pressure drop across the 
foam was measured by an increase in flow rates to determine the permeability. The flow 
rates measured ranged from 0 to 850 ml/min, or Darcy velocities between 0 to 0.071 m/s 
for each of the samples. Three types of pressure transducers were used for these 
measurements: 1) 0-10 inches of water differential pressure transducer (model # 
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Figure 30: Diagram of the permeability setup. 
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PX409-10WDWUV) 0.08% of range accuracy (Omega Engineering, Inc., Stamford, 
Connecticut), 2)  2.5 PSI differential pressure transducer (model # PX409-2.5WDWUV) 
0.08% of range accuracy, (Omega Engineering, Inc., Stamford, Connecticut) and 3) 30 
PSI absolute membrane pressure transducer (model PXM42MG7-400MBARGV) 0.25% 
of range accuracy (Omega Engineering, Inc., Stamford, Connecticut). In addition to the 
pressure transducers, a set of two rigid tubes were fashioned as a water manometer and a 
set of digital 30 PSI pressure gauges (Dwyer Instruments, Michigan City, IN) (Model: 
DPGWB-06) with 0.01 of range resolution, were used to determine the maximum 
pressure differential of the highest flow prior to measurement with the transducers 
(Figure 31).  
The pump consisted of a Verderflex® Smart, (Verderflex, England, U.K.)  L20 
series, peristaltic pump equipped with a non-standard six head roller on an isolated cart, 
for reduction of pulse within the system. In addition to the six head roller, 20 feet of 
large diameter (12.7 mm ID and 15.875 mm OD) flexible silicone tubing was placed 
after the pump just before five pulse dampeners. After the pulse dampeners, there was an 
additional 12 feet of semi-rigid flexible tubing (12.7 mm ID and 19.1 mm OD) and 
subsequently ten feet of rigid tubing (15.875 mm ID and 19.05 mm OD) before the 
pressure chamber.  A flow meter probe, attached to a small animal blood flow meter 
(model number T206) (Transonic Inc., Ithaca, NY) was placed after the five pulse 
dampeners to quantify the pulse within the system and for flow rate measurements. In an 
effort to further reduce the pulse of the system seen by the sample, the tank was also 
isolated on its own cart.  
 
 
 
Figure 31: Close up of the permeability measurement chamber and sample holder. 
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5.3.4 MRI Flow loop 
The MRI flow loop was similar to the permeability setup, as far as length of 
tubing in the system prior to and after the sample holders (Figure 32). However, the MRI 
setup consisted of rigid tubing after the flow meter and just before the tank and the 
chamber was different. All magnetic components were at least twenty feet from the bore 
of the MRI. All other materials less than 20 feet from the system were composed of 
polymer, nylon, rubber, silicone or fiberglass to ensure compatibility with the MRI 
(Figure 33). The sample chamber (Figure 34), allowed for the same samples that were 
measured via permeability to be imaged.  
5.3.5 MRI imaging 
MRI phase contrast imaging was performed on a MAGNETOM Verio 3T 
(Siemens, Malvern, PA) clinical imaging scanner, using the 4D Flow pulse sequence 59, 
written by Markl, et al. This sequence is based off of a FLASH sequence and a modified 
ICE reconstruction program. Scan parameters were: TE 6.445 ms, TR 37.6 ms, and a flip 
angle of 15˚. In plane VENC 0.30 m/s, Through-plane VENC 0.30 m/s, Echo Spacing of 
9.40 ms, min rise time of 10 ms, FOV 70 mm, Resolution of 0.5 x 0.5 x 0.5 mm3, a 
Bandwidth of 450 hz/pixel, one slab with 72 slices and a scan time of 1 hour and 52 
minutes and a distance factor of 20%, and 32 averages per scan. A solution of water and 
copper sulfate 1% by volume was used to increase contrast of the images. The images 
were based off of T1 contrast due to a short TR and short TE of the scan. Two additional 
samples were imaged using the same parameters as stated with a larger of slab thickness 
of 120 slices equivalent to 6 cm.   
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Figure 32: MRI flow loop. 
 
 
 
Figure 33: MRI setup. 
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Figure 34: Close up of MRI measurement chamber. 
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Four samples of SMP foam and an empty chamber were imaged using the 
previously stated parameters at 400 and 800 ml/minute that resulted in Darcy velocities 
of 0.0334 and 0.0668 m/s respectively. The four samples chosen for imaging represented 
permeability and densities that were from the mid areas of the foam. All image sets were 
processed via Matlab (MathWorks®, Natick, MA) and viewed in Tecplot (Tecplot®, 
Bellevue, WA). 
5.4 Results 
5.4.1 Foam characterization 
Figure 35 is a summary of SEM images of the amount of reticulation of the samples that 
were characterized in this study. The average density of the porous material was 
measured to be 0.013 ± 0.001 g/cm3, with average porosity of the material was 
calculated via equation, Θ = (ρneat –ρporous)/ ρneat, to be 98.82% and the volume expansion 
of the foam was determined to be 85 X for 33 samples measured. As these are non-
homogeneous blown foams, the densities, porosity, expansion ratio, aspect ratio and 
surface area were characterized for location within the batch were also measured and 
included measurements from the center, mid and outer portions of the foam (Figure 36 
and 37). The densities were 0.012 ± 0.001, 0.013 ± 0.001, and 0.014 ± 0.001g/cm3 for 
center, mid and outer regions of the foam respectively (Figure 36). The porosities were 
98.93, 98.86 and 98.74% and the expansion ratios were 93.1, 87.4 and 79.1% from the 
center, mid and outer regions of the foam respectively (Figure 36). The aspect ratios for 
the center, mid and outer regions were 1.4, 1.7 and 2.5 respectively (Figure 36 and 38). 	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Figure 35: SEM imaging of mechanically reticulated SMP foam. 
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Figure 36: Summary of foam characteristics for center, mid and outer regions of foam. 
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Figure 37: Histogram of density measurements of foam for total volume of foam. 
 
 
 
Figure 38: Example of the densification of foam from center to outer ring. 
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From micro CT (µ-CT) data the surface area of the struts of the foams were 
measured after the reconstructed data was made into a 3D model.  The surface area of 
the struts of the foam was determined to be approximately 10 cm2/cm3. The struts were 
characterized via this method because the resolution of the µ-CT imaging was not high 
enough to capture membranes (5.96 µm/voxel resolution). The surface area was 
approximated via 3D hexagonal and pentagonal models that matched the major and 
minor diameters measured from microscopy images for the three regions (Figure 39). 
From these 3D models the surface area and volume of each pore was measured within 
Maya 2014 (Autodesk Inc., San Rafael, CA), a 3D software package. The number of 
pores per cm3 was determined via subtraction of the sum of the pore volumes from total 
volume, such that the apparent density, mass and porosity of the modeled foam was 
equal to the measured apparent density of the foam from the three regions where the 
solid polymer has a density of 1.1 g/cm3. Figure 36 is a summary of all of the foam 
characterizations that were made.  
5.4.2 Permeability  
All cases were graphed and fitted to the FHDD algorithm and are represented in figures 
41, 43, and 45 and supplementary figures S1-9. The samples were also imaged via 
microscopy and are represented in figures 40, 42 and 44. The permeability of the control 
samples ranged from 1.1818 x10-10 to 2.6815 x10-10 m2 and the form factor ranged from 
1.096 x106 to 3.9582 x105 m-1 (Figure S1). The permeability of the 1 gram axially 
punched foam samples ranged from 1.6415 x10-9 to 3.6668 x10-9 m2 and the form factor 
ranged from 1.6744 x104 to 5.9197 x104 m-1 (Figure S2). The permeability of the 1 gram  
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Figure 39: 3D models used to calculate surface area based off of aspect ratio 
measurements and morphology of the foams. 
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Figure 40: Microscopy images of the control samples. 
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Figure 41: Permeability of all axial reticulated cases. 
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Figure 42: Microscopy imaging of all axial reticulated samples. 
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Figure 43: Permeability of tri axially reticulated cases. 
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Figure 44: Microscopy imaging of all tri axially reticulated samples. 
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axially punched and base etched foam samples ranged from 1.50556 x10-9 to 2.4589 x10-
9 m2 and the form factor ranged from 1.8515 x104 to 2.5855 x104 m-1(Figure S3). The 
permeability of the 2 gram axially punched foam samples ranged from 1.2924 x10-9 to 
4.5679 x10-9 m2 and the form factor ranged from 4.253 x103 to 1.5204 x104 m-1 (Figure 
S4). The permeability of the 2 gram axially punched and base etched foam samples 
ranged from 3.4054 x10-9 to 4.1671 x10-9 m2 and the form factor ranged from 8.9562 
x103 to 1.3153 x104 m-1(Figure S5). Figures 41 and 42 are a comparison of all axial 
cases via microscopy and permeability. The permeability of the 1 gram/1 gram tri axially 
punched foam samples ranged from 1.6001 x10-9 to 3.2762 x10-9 m2 and the form factor 
ranged from 4.6314 x103 to 5.9197 x103 m-1(Figure S6). The permeability of the 1 
gram/1 gram tri axially punched and base etched foam samples ranged from 2.1078 x10-
9 to 3.1708 x10-9 m2 and the form factor ranged from 5.7072 x103 to 8.3828 x103 m-1 
(Figure S7). The permeability of the 2 gram/1 gram tri axially punched foam samples 
ranged from 3.5927 x10-9 to 9.4619 x10-9 m2 and the form factor ranged from 4.2522 
x103 to 1.0657 x104 m-1 (Figure S8). The permeability of the 2 gram/1 gram tri axially 
punched and base etched foam samples ranged from 3.2404 x10-9 to 5.8288 x10-9 m2 
and the form factor ranged from 5.3521 x103 to 6.6565 x103 m-1 (Figure S9). Figure 43 
and 44 summarizes the permeability and morphology of all of the tri axial cases. Figure 
45 compares all cases on one graph. It was shown that all reticulated samples were an 
order of magnitude lower than the control samples in both permeability and form factor, 
which are summarized in figure 46 and 47 respectively. Figures 48 and 49 summarize 
the permeability and Form factor of the differently reticulated foams versus the idealized  
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Figure 45: Permeability of all samples. 
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Figure 46: Permeability (K values) determined from FHDD fit of the measurements. 
Algorithm used to fit the K and C to the -dp/dx versus v curves gives a 95% confidence 
interval for the K and C values. 
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Figure 47: Form factor, C values, determined from FHDD fit of the measurements. 
Algorithm used to fit the K and C to the -dp/dx versus v curves gives a 95% confidence 
interval for the K and C values. 
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Figure 48: Permeability versus idealized volume of material removed per cubic meter of 
solid material via mechanical reticulation. 
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Figure 49: Form factor versus idealized volume of material removed per cubic meter of 
solid material via mechanical reticulation. 
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density of the material removed from the samples. Figure 50 is a graph of the friction 
factor versus Reynolds number for all samples and compared to samples from a previous 
study that measured SMP foams. 
5.4.3 MRI imaging 
From imaging of the control samples it is shown that the flow is fully developed 
within imaging frame (Figure 51 and 52), which was also observed on the inlet portion 
of the foam. The observed average velocity of the flow was between 0 and 0.1 m/s prior 
to the foam. Overall, at the lower flow rate, 400 ml/min, the MRI signal obtained by 
imaging was less than what was observed in the higher flow rate, 800 ml/min. It was 
also shown that on average, there was acceleration up to 0.25 m/s, and a deceleration of 
the flow down to -0.25 m/s within the foam that resulted in a mixture of both faster and 
slower velocities distal to the foam. However, it appears that more acceleration occurred 
within the axial cases than in the tri axial cases. From imaging with the larger slab slice, 
it was shown that that flow did become fully developed further distal to the foam (Figure 
53 and 54).    
5.5 Discussion 
It has been shown that SMP foams have the potential to be aneurysm filler with 
superior healing responses in vivo.77 It has also been shown that varying the level of 
reticulation of the foam affects the clotting time of the foams in vivo.78 Characterization 
of the fluid interactions between the foam and water via permeability measurements and 
MRI imaging provided the preliminary steps towards observation of these materials in 
vivo. We were able to characterize the permeability of mechanically reticulated and  
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Figure 50: Friction factor versus Reynolds number for all cases and previous study 
reported by Muschenborn et. al, 2013, represented by foam l (large pore), foam s (small 
pore) and MECs (mock embolic coils). 
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Figure 51: Velocity vectors from 400 ml/minute flow in control (empty chamber), axial 
and tri axial chambers. Black outline represents approximate location of SMP foam, 
which is approximately 2 cm. 
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Figure 52: Velocity vectors from 800 ml/minute flow in control (empty chamber), axial 
and tri axial chambers. Black outline represents approximate location of SMP foam, 
which is approximately 2 cm. 
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Figure 53: Velocity vectors from 800 ml/minute flow in axial and base etched foam. 
Permeability of 3.9908 e-9 m2 and form factor of 1.3153 e+4 m-1. 
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Figure 54: Velocity vectors from 800 ml/minute flow in tri axial and base etched foam. 
Permeability of 5.4433 e-9 m2 and form factor of 6.6565 e+3 m-1. 
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etched SMP foam at less than 5 Pa pressure drops across the foam and MRI image flow 
within the foam at a resolution that was sub pore cell sizes. The ability to characterize 
these materials at this level of detail will help the future development of these materials 
as aneurysm filling devices. 
One drawback to characterization of these materials involved the creation of 
pathways for fluid to permeate into the pores for not only characterization, but also as a 
viable implantable material. This was due to the native closed cell morphology of this 
formulation of SMP foam. It became necessary to post cure process the foam via 
mechanical reticulation as a preliminary step as a means for the development of an SMP 
foam as an aneurysm filling device and also for characterization via permeability and 
MRV imaging. Currently, the optimal level of reticulation and morphology of SMP 
foam for thrombus formation within an SMP device is still unknown. In an effort to 
characterize different reticulation processes for these materials we looked at eight cases 
of reticulation and base etching and one control case. In order to characterize these 
materials under similar conditions in which the foam would experience in vivo, it was 
necessary to develop a permeability system that was sensitive enough to be able to 
measure small pressure drops across the sample at steady and low velocity flow rates.  
We were able to measure the permeability of mechanically reticulated foams with this 
system. This was a preliminary step toward optimization of design and fabrication of 
these foams as an SMP aneurysm-filling device. Beyond polymer design, permeability 
and morphology of these materials are also necessary parameters for computational fluid 
dynamics and understanding the basic fluid interactions with these materials in vivo.  
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The eight cases of post processing via reticulation and etching included axial and tri 
axial mechanically reticulated foams, which were shown to increase permeability by an 
at least an order of magnitude more than the control, or non-reticulated foams. An 
increase in the permeability of the foams permits more fluid to permeate throughout the 
volume of the foam. For the SMP foam to function as an aneurysm filler, or vasculature-
occluding device, it was necessary to create paths for which blood may permeate and 
stagnate to facilitate the clotting process. 
Mechanically reticulated foams in the axial direction increased permeability, K, 
by at least 10x more than the control foams. Tri axially reticulated foams increased 
permeability more than the axially reticulated foams by approximately 15x. These 
results imply that knowledge of the density, porosity anisotropy of the foams along with 
the level of reticulation one can potentially tailor the time and amount of clotting 
throughout the foam. However, optimization of these factors would vary between a 
vascular occluding device and an aneurysm-filling device. As a result, further studies 
would be necessary to determine the optimal characteristics of the foam devices.    
The form factor was decreased by one to two orders of magnitude via mechanical 
reticulation and base etching. This was expected, due to the fact that mechanical 
reticulation is the act of removing membranes or windows of closed celled foams while 
the struts remain intact.9 Through removal of the windows the cross-sectional area of 
porous material obstructing the flow perpendicular to the direction of the flow was 
decreased. In general, between the axial and tri axial cases, the form factor, f, decreased 
by an order of magnitude. The difference between the axial and tri axial samples was the 
  146 
removal of membranes in one axis versus three respectively. Therefore, the decrease in 
form factor between the two is a reasonable result.  
The difference between the two cases can be quantified via the hole density 
punched per face. The hole density of these samples was 4.0 x 106 holes/m2 per axis 
punched.  For reticulated cases, if it was assumed that a straight cylindrical path was 
traveled for every pin (0.008” or 203 µm diameter, punched every 0.5 mm) through a 
cubic meter volume during reticulation, this punching pattern would result in the 
potential removal of 0.125664 m3 and 0.286498 m3 of material per cubic meter for axial 
and tri axial cases respectively, represented in figures 48 and 49. By these assumptions, 
the differences between the two reticulation methods results in up to a 2.3X increase in 
removal of membranes throughout the volume. From the samples measured, there was 
an average 1.5X increase in the permeability between the axial and tri axial cases (figure 
48 and 49). In a previously reported permeability study performed on SMP foams65, the 
permeability ranged between 5.7 x 10-9 to 1.27 x10-8 and 3.25 x 10-9 to 1.15 x 10-8 and 
form factors ranged between 2.72 x 103 to 7.26 x 103 and 2.80 x 103 to 6.19 x 103 for 
small (diameter = 0.73 mm) and large (diameter = 1.1 mm) celled foams respectively. 
The samples previously reported had hole punching densities of 0.9 x 105, 1.7 x 105, 3.5 
x 105 and 6.9 x 105 holes/m2. Although the hole pattern density was lower by an order of 
magnitude, the previously reported values for permeability were on the same order of 
magnitude up to an order of magnitude larger than the samples reported here. This may 
have resulted from the difference in mechanical reticulation applied to these samples or 
the foams themselves, as these materials were different SMP foam formulations 
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The difference between the previously reported cases and the cases reported here, 
was the difference in the mechanical mechanism of reticulation for puncturing the 
membranes between the pores. Previously, 300 µm diameter stainless steel needles were 
manually punched through the foam, aided with a rigid template used to create straight 
channels within the SMP foam material. For the samples reported here, the membranes 
were removed via free-floating, weighted, gravity driven, mechanically agitated nitinol 
pin assemblies. For this method of reticulation, the larger cylindrical weighted portion of 
the pins were free to move in the z-axis within a channel, while the nitinol pin portion 
was able to flex and stop when too much resistance was encountered as they penetrated 
the material. This design allowed for more tortuous paths to be made throughout the 
foam while preserving the integrity of the struts. Due to the less direct paths associated 
with this reticulation method, it is reasonable that the overall permeability would be 
lower for these samples even though the punching density was an order of magnitude 
greater than the previously reported samples. The lower permeability achieved by this 
reticulation method may result in a better device to occlude vessels due to the necessity 
of flow stagnation to aid in thrombus formation.27 The previous study on SMP foams 
compared the permeability of two types of foams to mock embolic coils, and concluded 
that the SMP foams were more effective at reducing flow through the media and 
therefore, would be better suited to induce the desired hemodynamics within a treated 
aneurysm.65 
The form factor versus Reynolds number plot of the samples follows the 
mathematical model of form factor in the region of Reynolds number, Re, greater than 1. 
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However, in the region of the plot of Re less than 1, the trends follow a similar pattern 
but diverge from the model as the Re values decrease. The previously reported 
permeability data for the different SMP foams and mock embolic coils were added to the 
plot and they spanned Reynolds numbers between 0.5 and 50. The data reported for 
these samples covered Reynolds numbers between 0.01 to 10, which covers the range of 
Reynolds numbers used by Ortega et al. for blood flow simulation within SMP foam.70 
The friction factors of all samples reported here are larger than the previously reported 
number from Muschenborn et al. in 2013.  
Via MRV imaging we were able to visualize the interaction of the fluid within 
SMP foam while flow rates were varied. In general, it was shown that the lower flow 
rate, 400 ml/min, resulted in less tortuous flow patterns than the higher flow rate, 800 
ml/min. However, the more reticulated tri axial foams showed a lower amount of 
variation in flow. This was expected due to the straighter channels within the axially 
reticulated foam than the more tortuous pathways exhibited tri axially reticulated foams; 
imaging of axial reticulated cases is most likely analogous to imaging flow in capillary 
tubes previously reported by Romenenko, et al. in 2011.80 
We were able to visualize the average velocity vectors at a voxel resolution of 
0.5 x 0.5 x 0.5 mm3. Although this resolution is sub pore cell size, smaller voxels would 
result in more visualization and quantification of flow within the foam. In other words, 
at the resolution imaged, we are not able to conclusively say that each velocity vector 
actually depicts the fluid and SMP foam interaction as they occur within the foam. We 
are only able to conclude that on average the velocity vectors depicted was what was 
  149 
experienced within the foam. We were unable to image the non-reticulated, or control 
foams, due to the low permeability and high-pressure drop created across the sample. 
Another issue involved with imaging the control samples was the suspected resulting 
low signal from the small amount of native open membranes within the foam.  
Signal was low in foams that were not evacuated overnight prior to imaging. This 
was expected due to the trapped air within the foam, which prevents the permeation of 
copper sulfate solution for increased contrast throughout the foam. It was also seen that 
signal was better in the higher flow rates than in the lower flow rates. For that reason, 
imaging was performed in the mid and higher flow rates of 400 and 800 ml/min. The 
flow rates reported in this study are higher than the blood flow within a basilar artery 
(~70-170 ml/min) reported by Jou et al. in 2003.48 However, due to the large diameter of 
tubing that was used in these experiments, the Darcy velocities were very low and 
ranged between 0 and 0.071 m/s. Our Darcy velocities are much lower in comparison to 
the reported in Kato et al.53 values for a normal artery (0.17-0.5 m/s). We obtained our 
Darcy velocity values via matching Reynolds number and were limited due to the cross 
sectional area of the foam, tubing and the capabilities of the pump. Additionally, these 
lower velocities compliment previous CFD simulations performed in SMP foam within 
basilar artery aneurysms.70 The CFD results showed a significant deceleration in the 
fluid velocity within the foam70, which was further validation of the use of these 
velocities. In addition to the previously mentioned reasons, these lower Darcy velocities 
compliment the previous study involving measurement of permeability in SMP foam at 
greater Darcy velocities.65 
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Previously, SMP foam with pore cells of approximately 200-300 µm in diameter, 
a density of 0.020 g/cc, a calculated volumetric void fraction of 98.4%, with a sample 
dimension of 4-mm-diameter by 10-mm-long cylinder of was imaged within silicone 
tubing having an inner diameter of 2.5 mm and a velocity of 0.013 m/s resulting in the 
foam being compressed to 62.5% of its original diameter was imaged via phase contrast 
MRV.86 The resultant images had four slices with dimensions of 5 mm x 5 mm x 2 mm 
with a resolution of 39 µm x 39 x 2mm µm per voxel.86 Although the in-plane resolution 
was more than an order of magnitude better than this study, the resolution of the velocity 
in the direction of the flow was 2 mm, or one quarter the resolution of the images that 
were achieved in this study.  The imaging was performed with a “9.4 T with a Bruker 
Avance spectrometer and a Bruker Micro 2.5 microimaging probe equipped with a 5-
mm coil”.86 For this study imaging was performed on a 3T clinical scanner. An increase 
in resolution by a smaller voxel size is feasible however; it greatly increases the imaging 
time. For this study we chose shorter imaging time to increase the number of averages in 
the velocity vectors, number of samples and flow rates imaged. The ability to image 
these materials with a clinical scanner with reasonable resolution implies that these 
methods may be used in the future to image these materials with blood either in vitro or 
in vivo. These studies laid the groundwork for more advanced characterizations of these 
materials, thereby facilitating further optimization them for clinical applications.      
Basic characterizations of these foams were also performed in order to better 
understand the effects of the foam density, surface area, porosity and anisotropy. 
Although the foams were characterized in multiple locations via the previously 
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mentioned methods, not all densities were represented via permeability and MRI 
measurements. This would require much more samples, which was not feasible. Due to 
the heterogeneous nature of these blown foam materials, it has become evident that it 
was necessary to quantify the density and porosity of the material prior to sample 
preparation, evident by the variability in permeability of the materials after processing. 
Subsequently, this was also evident by the variation in form factor of samples that were 
prepared in the same manner, even though they were from the same batch of foam. 
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6. SUMMARY 
This research sought to characterize shape memory polymer (SMP) foams by 
evaluating their micro-structure, biocompatibility, radio-opacity, and characterize their 
interaction in the presence of flow. The intention was to incorporate these results into the 
development of SMP foam technology that will result in a commercially available 
embolic treatment for aneurysms. The structure of SMP foam is a complex architecture 
of mostly closed cells, including struts, membranes and pores. Its structure contributes 
not only to the physical properties of the material, but the devices and their interaction 
with blood in vivo. These interactions include the hemodynamic disruptions caused by 
the presence of the foams and the resultant overall healing seen in vivo when used as an 
aneurysm occluding device. A component of this research explored the microstructure of 
SMP foam by micro computed tomography (µ-CT) imaging that provided data for 
structural characterization of the foam. Knowledge of the microstructure of the foams in 
three dimensions, not only allows for diameter histogram data to be acquired, but also 
allows for more complex computation fluid dynamic simulations to be performed on the 
resultant 3D models of the foam. Biocompatibility of SMP foams was evaluated for 
implants up to 90 days within a vein pouch porcine animal model, which ultimately 
determined the feasibility of these materials as a viable implantable medical device. For 
clinical relevance, the positioning and delivery of an aneurysm-filling device, such as the 
SMP embolic foam device, must be radio-opaque, or possess the ability to attenuate X-
rays in order to be visible via fluoroscopy. One of the research goals of this research was 
to increase the radio-opacity of SMP foam. Beyond radio-opacity, this research also 
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demonstrated biocompatibility of the resultant composite materials that were made by 
making them radio-opaque. This research also set out to characterize fluid interactions 
between the foams when exposed to varied flow rates. The permeability of the porous 
media was characterized at varying flow rates, which compared to the clinically relevant 
flow rates that were demonstrated via computation fluid dynamics interactions. We were 
also able to visualize the hydrodynamic interaction between SMP foam and water with 
MRV at sub-pore cell size resolution, indicating that this technology could be adapted to 
visualization in vivo or with blood. This data may be an important first step toward 
understanding the initiation of clot formation within the volume of the aneurysm filling 
foam device; a valuable component of the biocompatibility of an aneurysm device.  
6.1 Topics covered 
6.1.1 Microstructure of SMP foams 
First, I proposed to image SMP foam samples using micro-Computed 
tomography (µ-CT), using settings that will achieve high resolution (<5 µm/pixel) 
images, to be used for assessment of microstructure. This data was to be analyzed in 
three dimensions to characterize of the architecture of the foam. Assessment of the 
structure included such characteristics as a range of average pore cell diameters, strut 
length, and isotropy of the pores. Beyond characterization of foam, this data was used 
for 3D models to be used in computational fluid dynamics (CFD) simulations. This aim 
was met with the publication of the articles entitled “Ultra low density and highly 
crosslinked biocompatible shape memory polyurethane foams”, published by Singhal et 
al. in 201285 and “Virtual treatment of basilar aneurysms using shape memory polymer 
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foam”, published by Ortega et al. in 2013.70 Expanding on this aim, data was also used 
in section five of this dissertation for the proposed publication of “4D Flow 
Visualization and Permeability of Mechanically Reticulated Shape Memory Polymer 
Foam for Aneurysm Treatment”, by Rodriguez, et al. in 2014, in which the surface area 
of the foam was estimated via aspect ratio dimensions of the foam, the relative density of 
the foams and three dimensional models of individual pore cells. Possession of the 
complex 3D models and surface area of the foams helps to further increase the 
refinement of computational fluid dynamics simulations performed at Lawrence 
Livermore National Laboratory.  
6.1.2 Biocompatibility of SMP foam  
Second, I proposed to determine the biocompatibility of an SMP foam device 
when implanted in a porcine vein pouch aneurysm model. This aim was met with the 
publication of the articles entitled “In vivo response to an implanted shape memory 
polyurethane foam in a porcine aneurysm model” and “Opacification of shape memory 
polymer foam designed for treatment of intracranial aneurysms” by Rodriguez, et al. in 
201477 and 201279 respectively. Both of these articles reported the biocompatibility of 
implanted SMP foams as aneurysm fillers within a porcine vein pouch aneurysm model. 
The latter of the two papers reported biocompatibility of tungsten doped SMP foams.  
6.1.3 Radio-opacity and ppacification of SMP 
Third, I proposed to determine the native opacity of our neat and foam versions 
of polyurethane SMP when imaged using X-ray based imaging methods, such as 
fluoroscopy. Once this data was acquired, I determined if there is a necessity for the 
  155 
addition of High-Z element filler to the polymer that will aid in the attenuation of X-
rays. X-rays are used in fluoroscopy, the imaging technology used by clinicians to place 
aneurysm filler devices. I proposed to determine the minimal concentration of High-Z 
element filler that is necessary for visualization of a crimped SMP foam device in vivo. 
Experimentally it was determined that High-Z element filler was necessary for X-ray 
attenuation. It was determined that tungsten at 4% by volume was sufficient at creating 
enough radio-opacity in vivo when imaged with a porcine skull via fluoroscopy at small 
diameters. In addition to radio-opacity and biocompatibility, we demonstrated that by 
doping with a High-Z element particulate we can increase the mechanical properties of 
these materials. In essence the opacification research resulted in a composite material 
that was tougher than the original foams. This aim was met with the publication of the 
article entitled “Opacification of shape memory polymer foam designed for treatment of 
intracranial aneurysms” by Rodriguez, et al. in 2012.79 
6.1.4 Imaging flow within an SMP foam using magnetic resonance imaging (MRI) 
Fourth, I proposed to visualize the flow, specifically the mean velocity vectors of 
fluid within an SMP foam using magnetic resonance imaging (MRI), more specifically, 
magnetic resonance velocimetry (MRV). To achieve this goal I proposed to visualize a 
fluid within a SMP foam plug within a cylindrical model under constant flow at varying 
flow rates. Beyond imaging flow I also proposed to characterize the permeability of 
SMP foam. In order to achieve these goals, reticulation of SMP was necessary due to the 
native closed cell morphology of the foam. A sub aim of this fourth aim was to develop 
a non-destructive means for reticulation of the SMP foam. This was a large sub-aim, 
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which should have been an aim unto itself, as this aim was met with the intended 
publication of the article entitled “Reticulation of low density shape memory polymer 
foam for vascular occlusion” by Rodriguez, et al. in preparation for submission in 
2014.78  
This publication not only covers the process of mechanical reticulation used to 
open up the membranes of the foam, it also demonstrated the use of SMP foam as a 
vascular occlusion device in vivo within a porcine animal model. By varying the 
reticulation of SMP foam and implanting them as a vascular occlusion device we 
demonstrated that it might be possible to tailor future devices via mechanical reticulation 
for the optimal occlusion time based on further animal results. Finally, this aim was met 
with the intended publication of the article entitled “4D Flow Visualization and 
Permeability of Mechanically Reticulated Shape Memory Polymer Foam for Aneurysm 
Treatment” by Rodriguez, et al., also in preparation for submission in 2014. In this 
publication the permeability and MRV imaging of mechanically reticulated SMP foams 
were reported. 
6.2 Impact of topics covered 
Completion of these aims increased the understanding of the SMP foam devices 
and their overall interaction in vivo. The micro architecture of the foam impacts the 
mechanical behavior of the foams and how they interact with the body during the 
healing process. This knowledge of the micro architecture, aspect ratio, expansion ration 
and porosity, also determines the amount of material that can be compacted into one 
device during the temporary programming of the SMP. In effect, these characteristics 
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determine the amount of material that can be used for an occluding device that will be 
delivered via endovascular methods. Knowledge of their microstructure also determined 
that the individual pores need to be reticulated to allow for blood flow to permeate and 
begin the initial healing process.  
After the foams have been mechanically reticulated by different means, by 
varying the axes punched, this changes their permeability. This change in the impedance 
of blood flow throughout the device has an impact on how long it takes for the device to 
occlude within the vessel and how completely the foam fills with blood. How 
completely the foam fills with blood in turn has an impact on how well the foams are 
incorporated into the healing tissue of the aneurysms. The clot acts as the architecture for 
which cellular components can come in and resolve the residual clot and lay down 
collagen, thereby stabilizing the aneurysm from future rupture.  
The biocompatibility of an implanted device was determined at multiple time 
points and it was demonstrated that the foams were approximately 75% filled with 
cellular infiltrates, had low inflammation when compared to the suture materials used to 
make the aneurysms, and the device was isolated from the parent vessel with an 
endothelial cell layer. These results showed that SMP foam as aneurysm filling device is 
successful at achieving what both the GDC coils and surgical clipping aim to do, isolate 
the weakened portion of the vessel from the rest of the parent vasculature preventing 
future rupture.   
Second to biocompatibility is visibility, or radio-opacity when the foam is 
implanted into an aneurysm, as far as the feasibility of these materials as becoming an 
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endovascularly deployed medical device. Radio-opacity was achieved by doping the 
foam with 4% by volume tungsten particulates. This process not only enabled contrast of 
the foam to be visible with the skull thickness of a pig, but was shown to be a tougher 
material and also biocompatible when implanted in vivo. We have shown that the 
particulates can be incorporated into these materials to increase mechanical properties 
and elicit radio-opacity, which can also be incorporated into future variations of these 
materials.  
Healing is initiated by the clot formation within the foam that occurs within 
minutes of being exposed to blood with these materials. Varying the permeability by 
varying the reticulation of the foams allows for the future tailoring and design of 
occlusion devices by these materials. By characterizing the flow and fluid characteristics 
within the foam, it may be possible to predict the initial clotting process in vivo with 
computational fluid dynamics. CFD can also be validated by MRV imaging within the 
foam. With the proper settings, one could image the foam within an aneurysm as it was 
clotting using MRV methods.  All of this research sought to advance these materials 
closer toward application as a viable medical device and to understand some basic 
science about the fluid and foam interactions. These characteristics are important factors 
that should be observed prior to commercialization of a medical device made of these 
materials. This research was a significant step toward the realization of these materials 
being used as aneurysm fillers within humans.  
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  Table S1: Summary of residual fibrin remaining in the aneurysm dome determined by histology. 
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Figure S1: Permeability of the control samples. 
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Figure S2: Permeability of 1gram axial reticulated cases. 
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Figure S3: Permeability of 1 gram axial and base etched reticulated cases. 
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Figure S4: Permeability of 2 gram axial reticulated cases. 
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Figure S5: Permeability of 2 gram axial and base etched reticulated cases. 
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Figure S6: Permeability of 1g/1g tri axially reticulated cases. 
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Figure S7: Permeability of 1g/1g tri axially and base etched reticulated cases. 
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Figure S8: Permeability of 2g/1g tri axially reticulated cases. 
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Figure S9: Permeability of 2g/1g tri axially and base etched reticulated cases. 
